مرکز تحقیقات سرطان

بازدید: 366
امتیاز:
( 0 Rating )

مقالات به روز شده

امتیاز کاربران

ستاره غیر فعالستاره غیر فعالستاره غیر فعالستاره غیر فعالستاره غیر فعال
 
  1. Askarian S, Gholami M, Khalili-Tanha G, Tehrani NC, Joudi M, Khazaei M, et al. The genetic factors contributing to the risk of cleft lip-cleft palate and their clinical utility. Oral and Maxillofacial Surgery. 2022:1-10.
  2. Alidoust M, Hamzehzadeh L, Khorshid Shamshiri A, Afzaljavan F, Kerachian MA, Fanipakdel A, et al. Association of SMAD7 genetic markers and haplotypes with colorectal cancer risk. BMC medical genomics. 2022;15(1):1-9.
  3. Elyasi S, Rasta S, Taghizadeh-Kermani A, Hosseini S. Topical henna and curcumin (Alpha®) ointment efficacy for prevention of capecitabine induced hand-foot syndrome: A randomized, triple-blinded, placebo-controlled clinical. DARU Journal of Pharmaceutical Sciences. 2022;30(1):117-25.
  4. Javid H, Ghahremanloo A, Afshari AR, Salek R, Hashemy SI. The Emerging Role of Neurokinin-1 Receptor Blockade Using Aprepitant in the Redox System of Esophageal Squamous Cell Carcinoma. International Journal of Peptide Research and Therapeutics. 2022;28(3):1-13.
  5. Hasanzadeh M, Homaee Shandiz F, Izadpanahee N, Mottaghi M. Is There a Role for Surgery in the Management of Gestational Trophoblastic Neoplasia? Middle East Journal of Cancer. 2022;13(1):128-34.
  6. Nesaei A, Naderi Ghale-noie Z, Khorshid Shamshiri A, Afzaljavan F, Rivandi M, Tajbakhsh A, et al. 2q35-rs13387042 variant and the risk of breast cancer: a case–control study. Molecular Biology Reports. 2022:1-9.
  7. Manouchehri E, Taghipour A, Ghavami V, Shandiz FH, Ebadi A, Roudsari RL. Menstrual and reproductive factors and risk of breast cancer in iranian female population: A systematic review and meta-analysis. International Journal of Preventive Medicine. 2022;13.
  8. Manouchehri E, Taghipour A, Ebadi A, Homaei Shandiz F, Latifnejad Roudsari R. Understanding breast cancer risk factors: is there any mismatch between laywomen perceptions and expert opinions. BMC cancer. 2022;22(1):1-11.
  9. Rahmani F, Ziaeemehr A, Alijannejad S, Ferns GA, Khazaei M, Shahidsales S, et al. A mini review on the pathogenesis, diagnosis and treatment options for COVID-19. Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious Disorders). 2022;22(2):13-21.
  10. Moezian GSA, Javadinia SA, Sales SS, Fanipakdel A, Elyasi S, Karimi G. Oral silymarin formulation efficacy in management of AC-T protocol induced hepatotoxicity in breast cancer patients: a randomized, triple blind, placebo-controlled clinical trial. Journal of Oncology Pharmacy Practice. 2021:10781552211006182.Yazdi SAT, Safaei M, Gholamin M, Abdollahi A, Nili F, Nooghabi MJ, et al. Expression and Prognostic Significance of Cancer/Testis Antigens, MAGE-E1, GAGE, and SOX-6, in Glioblastoma: An Immunohistochemistry Evaluation. Iranian journal of pathology. 2021;16(2):128.
  11. Yazdi SAT, Safaei M, Gholamin M, Abdollahi A, Nili F, Nooghabi MJ, et al. Expression and Prognostic Significance of Cancer/Testis Antigens, MAGE-E1, GAGE, and SOX-6, in Glioblastoma: An Immunohistochemistry Evaluation. Iranian journal of pathology. 2021;16(2):128.
  12. Fazilat‐Panah D, Ahmadi N, Moslemi D, Karimi M, Taji A, Dehghani M, et al. A case report of prostate adenocarcinoma with leptomeningeal carcinomatosis and intracerebral metastasis. Clinical Case Reports. 2021;9(10):e05000.Tajbakhsh A, Farjami Z, Nesaei-Bajestani A, Afzaljavan F, Rivandi M, Moezzi A, et al. Evaluating the association between ccr5delta32 polymorphism (Rs333) and the risk of breast cancer in a cohort of iranian population. Iranian Journal of Public Health. 2021;50(3):583-91.
  13. Taghizadeh-Hesary F, Porouhan P, Soroosh D, PeyroShabany B, Shahidsales S, Keykhosravi B, et al. COVID-19 in Cancer and Non-cancer Patients. International Journal of Cancer Management. 2021;14(4).
  14. Tabriz ER, Ramezani M, Heydari A, Aledavood SA. Health-Promoting Lifestyle in Colorectal Cancer Survivors: A Qualitative Study on the Experiences and Perspectives of Colorectal Cancer Survivors and Healthcare Providers. Asia-Pacific Journal of Oncology Nursing. 2021;8(6):696.
  15. Shandiz FH, Torghabeh AE. Ovarian immature teratoma grade II in pregnancy, two cases report and literature review. Authorea Preprints. 2021.
  16. Shahidsales S, Aledavood SA, Joudi M, Molaie F, Esmaily H, Javadinia SA. COVID-19 in cancer patients may be presented by atypical symptoms and higher mortality rate, a case-controlled study from Iran. Cancer Rep (Hoboken). 2021:e1378.
  17. Salek R, Dehghani M, Mohajeri SA, Talaei A, Fanipakdel A, Javadinia SA. Amelioration of anxiety, depression, and chemotherapy related toxicity after crocin administration during chemotherapy of breast cancer: A double blind, randomized clinical trial. Phytotherapy Research. 2021;35(9):5143-53.
  18. Ramezani Farkhani R, Gholamhosseinian H, Anvari K, Forghani M. Assessment of Thyroid Lobe Dose in Breast Cancer Intraoperative Radiotherapy. Journal of Biomedical Physics & Engineering. 2021;11(1):55.
  19. Rahmani F, Ziaeemehr A, Alijannejad S, Ferns GA, Khazaei M, Shahidsales S, et al. A mini review on the pathogenesis, diagnosis and treatment options for COVID-19. Infect Disord Drug Targets. 2021.
  20. Motie MR, Taghizadeh A, Pourali L, Oshibnetaj M, Hasanzadeh E, Jarahi L, et al. Breast Cancer Risk Factors: A Case-Control Study in Iranian Women. Middle East Journal of Cancer. 2021;12(3):439-46.
  21. Mohtasham N, Ghazi N, Anvari K, Mohajertehran F, Organji T, Shahabinejad M. Evaluation of the Relationship Between the Invasive Front of Oral Squamous Cell Carcinoma and Clinicopathological Parameters. Iranian Journal of Pathology. 2021;16(3):316.
  22. Mohebbi E, Hadji M, Rashidian H, Rezaianzadeh A, Marzban M, Haghdoost AA, et al. Opium use and the risk of head and neck squamous cell carcinoma. Int J Cancer. 2021;148(5):1066-76.
  23. Mofrad SA, Nasiri A, Rad GHM, Shandiz FH. Spousal sexual life issues after gynecological cancer: a qualitative study. Supportive Care in Cancer. 2021;29(7):3857-64.
  24. Moezian GSA, Javadinia SA, Sales SS, Fanipakdel A, Elyasi S, Karimi G. Oral silymarin formulation efficacy in management of AC-T protocol induced hepatotoxicity in breast cancer patients: A randomized, triple blind, placebo-controlled clinical trial. Journal of Oncology Pharmacy Practice. 2021:10781552211006182.
  25. Mobaraki F, Momeni M, Yazdi MET, Meshkat Z, Toosi MS, Hosseini SM. Plant-derived synthesis and characterization of gold nanoparticles: Investigation of its antioxidant and anticancer activity against human testicular embryonic carcinoma stem cells. Process Biochemistry. 2021.
  26. Memarpour S, Khalili-Tanha G, Ghannad AA, Razavi MS, Joudi M, Joodi M, et al. The Clinical Application of Circulating Tumor Cells and DNAs as Prognostic and Predictive Biomarkers in Gastrointestinal Cancer. Current Cancer Drug Targets. 2021.
  27. Karimi F, Amiri-Moghaddam SM, Bagheri Z, Bahrami AR, Goshayeshi L, Allahyari A, et al. Investigating the association between rs6983267 polymorphism and susceptibility to gastrointestinal cancers in Iranian population. Molecular Biology Reports. 2021;48(3):2273-84.
  28. Javadinia S, Anvari K, Seilaniantousi M, Saghafi M. 354P Extended dosing (12 cycles) vs. conventional dosing (6 cycles) of adjuvant temozolomide in adults with newly diagnosed high grade gliomas: A randomized, single-blind, two-arm, parallel-group controlled trial. Annals of Oncology. 2021;32:S520-S1.
  29. Hosseini S, Rezaei S, Moghaddam MRN, Elyasi S, Karimi G. Evaluation of oral nano-silymarin formulation efficacy on prevention of radiotherapy induced mucositis: A randomized, double-blinded, placebo-controlled clinical trial. PharmaNutrition. 2021;15:100253.
  30. Homaei Shandiz F, Ghavami V, Akbari Sharak N, Saghafi MR, Hajebi Khaniki S. Association of Postoperative Radiotherapy Delay with Relapse and Metastasis in Women with Breast Cancer Using Penalized Cox Regression. Middle East Journal of Cancer. 2021.
  31. Homaei Shandiz F, Emadi Torghabeh A. Management of ovarian immature teratoma grade‐II in pregnancy, two cases report and literature review. Clinical Case Reports. 2021;9(7):e04456.
  32. Homaei Shandiz F, Afzaljavan F, Tajbakhsh A, Rivadeh M, Sharifi N, Shakeri MT, et al. Age-related Variation in Expression of Breast Cancer Tumour Markers in Iranian Patients. Middle East Journal of Cancer. 2021;12(2):269-75.
  33. Hashemian Moghadam A, Aghamohammadian Sharbaf HR, AbdeKhodaei MS, Kareshki H, Joudi M. Investigation of Structural Relationships of Factors Affecting Posttraumatic Growth in Women With Breast Cancer. Journal of Holistic Nursing And Midwifery. 2021;31(4):280-90.
  34. Hadji M, Rashidian H, Marzban M, Gholipour M, Naghibzadeh-Tahami A, Mohebbi E, et al. The Iranian Study of Opium and Cancer (IROPICAN): Rationale, design, and initial findings. 2021.
  35. Ghavami V, Mahmoudi M, Foroushani AR, Baghishani H, Yaseri M, Shandiz FH. A competing risks cure frailty model: An application to relapse-free survival of breast cancer patients. Pakistan Journal of Statistics and Operation Research. 2021:591-605.
  36. Gharib M, Homaei Shandiz F, Maddah G, Mehdizadeh B. A Case Report of Anaplastic Variant Juvenile Granulosa Cell Tumour. The Iranian Journal of Obstetrics, Gynecology and Infertility. 2021;24(3):95-100.
  37. Fazilat‐Panah D, Dehghani M, Ahmadi N, Karimi M, Soleimani Varaki S, Emadi Torghabeh A, et al. A case report of endometrial adenocarcinoma with leptomeningeal metastases. Clinical Case Reports. 2021;9(9):e04791.
  38. Farazestanian M, Hassanzadeh M, Yousefi Z, Homaee F, Saghafi N, Jafarian AH, et al. Pregnancy Before Completion of Follow-Up in Gestational Trophoblastic Neoplasia: a Case Report. Women’s Health Bulletin. 2021;8(3).
  39. Fanipakdel A, Hosseini S, Javadinia SA, Afkhami Jeddi F, Vasei M. The Prognostic Role of Body Mass Index in Survival of Non-metastatic Postoperative Patients with Colorectal Cancer. International Journal of Cancer Management. 2021;14(3).
  40. Fani Pakdel A, Hatami A, Salek R, Taghizadeh-Kermani A, Javadinia SA, Ghorbani A. Effects of a polyherbal formulation on the quality of life and survival of patients with common upper gastrointestinal cancers: A randomized placebo-controlled trial. Avicenna Journal of Phytomedicine. 2021.
  41. Esmaeili E, Taghizadeh A, Salek R, Yazdanpanah MJ, Mosanan Mozaffari H. diagnosis of an occult gastric adenocarcinoma by oral manifestations (acanthosis nigricans): a case report. Caspian Journal of Internal Medicine. 2021;12:7-0.
  42. Bani N, Moetamani-Ahmadi M, Alidoust M, ShahidSales S, Khazaei M, Esmaily H, et al. Association between the 308 G> A variant of the TNF-α gene and risk of colorectal cancer. Meta Gene. 2021;28:100878.
  43. Bahreini Toosi MT, Soleymanifard S, Farkhari A, Homaei Shandiz F, Salari E. Comparison of Radiotherapy Techniques in Breast Cancer with Inclusion of Internal Mammary Nodes through Thermoluminescent Dosimetry in a RANDO Phantom. Iranian Journal of Medical Physics. 2021;18(4):270-7.
  44. Bahrayni Toosi MT, Kasiri A, Torabinejad S, Soleymanifard S, Sankian M, Aledavood SA, et al. Preliminary Results of the Effects of Localized High-Dose Radiotherapy Combined with Total Body Low-Dose Irradiation on Tumor Growth and Stimulating the Immune System in Tumor-Bearing Mice. Journal of Biomedical Physics and Engineering. 2021.
  45. Amerizadeh F, Moetamani-Ahmadi M, Shahidsales S, Rahmani F, Gharib M, Hosseini TM, et al. The association of a genetic variant in multi-drug resistance gene and colorectal cancer susceptibility. Gene Reports. 2021:101252.
  46. Alwan AM, Afzaljavan F, Tavakol Afshari J, Homaei Shandiz F, Barati Bagherabad M, Vahednia E, et al. The impact of CYP19A1 variants and haplotypes on breast cancer risk, clinicopathological features and prognosis. Molecular genetics & genomic medicine. 2021:e1705.
  47. Alinejad Mofrad S, Nasiri A, Mahmoudirad G, Homaei Shandiz F. Challenges in the Marital Life of Women with Gynecological Cancers: A Qualitative Study. Modern Care Journal. 2021;18(2).
  48. Alimardani M, Moghbeli M, Rastgar-Moghadam A, Shandiz FH, Abbaszadegan MR. Single nucleotide polymorphisms as the efficient prognostic markers in breast cancer. Current Cancer Drug Targets. 2021.
  49. Aledavood SA, Anvari K, Shahidsales S, Hosseini S, Emadi Torghabeh A, Masudian M. Post-neoadjuvant chemoradiotherapy tumor resectability following induction chemotherapy in locally advanced proximal gastric and adenocarcinoma of the esophagogastric junction: A clinical trial. Caspian Journal of Internal Medicine. 2021;12(3):256-62.
  50. Zardadi M, Sima H, Joudi M, Ghafarzadegan K, Lari S, Taghizadeh A. Heat shock proteins 27, 70 and 90 protein expression in gastric adenocarcinoma: Prognostic, predictive and cellular differentiation significances. Middle East Journal of Cancer. 2020;11(1):21-32.
  51. Yaghoubi A, Khazaei M, Avan A, Hasanian SM, Soleimanpour S. The bacterial instrument as a promising therapy for colon cancer. International Journal of Colorectal Disease. 2020;35(4):595-606.
  52. Shandiz FH, Pasdar A, Afzaljavan F, Takalluo Z, Mofrad MH. Major Risk Factors for Cervical Cancer in Northeast of Iran: Evidence from a Case-Control Study. Basic and Clinical Cancer Research. 2020;12(2):91-7.
  53. Shandiz FH, Aledavood SA, Delghandi R, Fani M, Gholoobi A, Mashhadi SMY, et al. Epidemiology and Clinical Characteristics of Patients with Hepatocellular Carcinoma in North-East of Iran. Archives of Medical Laboratory Sciences. 2020;4(4).
  54. Shamshiri AK, Afzaljavan F, Alidoust M, Taherian V, Vakili F, Moezzi A, et al. ESR1 gene variants, haplotypes and diplotypes may influence the risk of breast cancer and mammographic density. Molecular Biology Reports. 2020;47(11):8367-75.
  55. ShahidSales S, Mehramiz M, Radmanesh D, Rastgar-Moghadam A, Hassanian SM, Khazaei M, et al. The association between genetic variants in the genes for cytochrome P450 B1 and ATP-binding cassette transporter genes and breast cancer risk. Molecular Biology Reports. 2020;47(8):6009-14.
  56. Shahidsales S, Farazestanian M, Sharifi‐sistani N, Rasta S, Javadinia SA. The uterine adenosarcoma in a young woman treated by tah/bos and combined adjuvant therapy: A case report. Acta Medica Iranica. 2020;58(3):138-41.
  57. Shahidsales S, Anvari K, Javadinia SA, Ghaderi F, Gholamhosseinian H, Fanipakdel A, et al. Investigation of Association Between Cardiac Dose Distribution and Strain/Tissue Doppler Echocardiographic Indices During 1-Year Post-Mastectomy Radiation Therapy Follow-Up in Breast Cancer Patients. Indian Journal of Gynecologic Oncology. 2020;18(3).
  58. Seifi S, Pouya F, Rahmani M, Mehramiz M, Rastgar-Moghadam A, Gharib M, et al. Association of cyclin-dependent kinase inhibitor 2A/B with increased risk of developing breast cancer. Journal of Cellular Physiology. 2020;235(6):5141-5.
  59. Sangsefidi ZS, Norouzy A, Safarian M, Kashanifar R, Pourbaferani R, Ghafouri-Taleghani F, et al. The Association between Dietary Intakes and Differentiated Thyroid Cancer: A Cross-Sectional Study among Patients and Healthy People in Iran. Journal of Nutrition and Food Security. 2020;5(2):109-17.
  60. Salehi M, Salehi M, Shahidsales S, Goshayeshi G, Emadzadeh M, Toosi MS, et al. Epidemiology of lung cancer in northeast of iran: A 25-year study of 939 patients. Medical Journal of the Islamic Republic of Iran. 2020;34(1).
  61. Sabouri S, Esmaily H, Shahidsales S, Emadi M. Survival prediction in patients with colorectal cancer using artificial neural network and cox regression. International Journal of Cancer Management. 2020;13(1).
  62. Rostami A, Naseri S, Momennezhad M, Zare H, Anvari K, Badkhor HS. Geometric distortion evaluation of magnetic resonance images by a new large field of view phantom for magnetic resonance based radiotherapy purposes. International Journal of Radiation Research. 2020;18(4):733-42.
  63. Rasta S, Hasanzadeh MM, Emadi TA, Sharifi N. Prognostic Value of Frozen Section and Touch Imprint Cytology for Intra-operative Differentiation of Benign and Malignant Ovarian Tumors. 2020.
  64. Rahmani F, Ziaeemehr A, Shahidsales S, Gharib M, Khazaei M, Ferns GA, et al. Role of regulatory miRNAs of the PI3K/AKT/mTOR signaling in the pathogenesis of hepatocellular carcinoma. Journal of Cellular Physiology. 2020;235(5):4146-52.
  65. Rahmani F, Tadayyon Tabrizi A, Hashemian P, Alijannejad S, Rahdar HA, Ferns GA, et al. Role of regulatory miRNAs of the Wnt/ beta-catenin signaling pathway in tumorigenesis of breast cancer. Gene. 2020;754:144892.
  66. Rahmani F, Ferns GA, Talebian S, Nourbakhsh M, Avan A, Shahidsales S. Role of regulatory miRNAs of the PI3K/AKT signaling pathway in the pathogenesis of breast cancer. Gene. 2020;737.
  67. Rahmani F, Avan A, Amerizadeh F, Ferns GA, Talebian S, Shahidsales S. The association of a genetic variant in cdkn2a/b gene and the risk of colorectal cancer. EXCLI Journal. 2020;19:1316-21.
  68. Rad MA, Fanipakdel A, Vossoughinia H, Dadgarmoghaddam M, Esmaeili B, Jafarian AH, et al. Demographic and clinical evaluation of patients with pancreatic cancer in Mashhad university of medical sciences during 2002-2013. Current Cancer Therapy Reviews. 2020;16(2):127-35.
  69. Nourbakhsh M, Hosseinzade A, Chamani J, Sazgarnia A, Salek R. Study of Synergistic and Protective Effects of Three Different Polar Saffron Extracts and Photon Radiation on Human Colorectal Cancer Cells (HT-29) and Normal Human Fibroblasts. International Journal of Cancer Management. 2020;13(12).
  70. Noghreiyan VV, Nasseri S, Anvari K, Naji M, Momennezhad M. Evaluation of set-up errors and determination of set-up margin in pelvic radiotherapy by electronic portal imaging device (EPID). Journal of Radiotherapy in Practice. 2020;19(2):150-6.
  71. Noghreiyan VV, Emami F, Salek R, Nasseri S, Vosoughi H, Momennezhad M. Contribution of 68Ga-PSMA PET/CT to targeting volume delineation of prostate cancer treated with conformal radiation therapy: Which SUV threshold is appropriate? Iranian Journal of Nuclear Medicine. 2020;28(2):20-9.
  72. Movahed S, Seilanian Toussi M, Pahlavani N, Motlagh AG, Eslami S, Nematy M, et al. Effects of medical nutrition therapy compared with general nutritional advice on nutritional status and nutrition-related complications in esophageal cancer patients receiving concurrent chemoradiation: A randomized controlled trial. Mediterranean Journal of Nutrition and Metabolism. 2020;13(3):265-76.
  73. Movahed S, Norouzy A, Motlagh AG, Eslami S, Khadem-Rezaiyan M, Emadzadeh M, et al. Nutritional status in patients with esophageal cancer receiving chemoradiation and assessing the efficacy of usual care for nutritional managements. Asian Pacific Journal of Cancer Prevention. 2020;21(8):2315-23.
  74. Mousavi M, Elyasi S, Esmaeili M, Kooshyar MM, Pakdel AF. Chemotherapy administration safety standards for preventing medication error in patients with hodgkin and non-hodgkin lymphoma. Middle East Journal of Cancer. 2020;11(2):203-8.
  75. Moradi Binabaj M, Bahrami A, Khazaei M, Ryzhikov M, Ferns GA, Avan A, et al. The prognostic value of cyclin D1 expression in the survival of cancer patients: A meta-analysis. Gene. 2020;728.
  76. Momeni S, Toosi MTB, Anvari K, Gholamhosseinian H, Soleymanifard S. Comparing two radiotherapy techniques of whole central nervous system tumors, considering tumor and critical organs' dose provided by treatment planning system and direct measurement. Journal of Cancer Research and Therapeutics. 2020;16(6):1470.
  77. Mohammadi Daloyi F, Sharifi N, Homaei Shandiz F, Jarahi L. PTEN Gene Expression and Tamoxifen-Resistance in Steroid Hormone Receptor Positive Breast Cancer Patients, a cross-sectional study between 2006 and 2016. The Iranian Journal of Obstetrics, Gynecology and Infertility. 2020;23(2):9-19.
  78. Laliani G, Ghasemian Sorboni S, Lari R, Yaghoubi A, Soleimanpour S, Khazaei M, et al. Bacteria and cancer: Different sides of the same coin. Life Sciences. 2020;246.
  79. Khaniki SH, Fakoor V, Sales SS, Esmaily H, Miri HH. Risk of relapse and death from colorectal cancer and its related factors using non-Markovian Multi-State model. Gastroenterology and Hepatology from Bed to Bench. 2020;13(3):200-8.
  80. Khadivi E, Khazaeni K, Mostaan LV, Salehi M, Vakili I, Javadinia SA, et al. A study on the effects of polite yawning technique on rehabilitation of olfaction after total laryngectomy. International Journal of Cancer Management. 2020;13(7):1-5.
  81. Keramati A, Javadinia SA, Gholamhosseinian H, Fanipakdel A, Shandiz FH, Taghizadeh-Hesary F. A Review of Intraoperative Radiotherapy After Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer: From Bench to Bedside. Indian Journal of Gynecologic Oncology. 2020;18(4):1-11.
  82. Karimi FZ, Homaee Shandiz F, Abdollahi M, Khosravi Anbaran Z. Investigating Functional and Symptom Scales of Quality of Life and Its Effective Factors among Patients with Breast Cancer during Chemotherapy. Middle East Journal of Cancer. 2020;11(2):209-15.
  83. Javadinia S, Shahidsales S, Anvari K, Gholamhosseinian H, Ghaderi F. PO-0950: Tissue Doppler and Strain Echocardiographic Indices of heart after PMRT in Breast Cancer Patients. Radiotherapy and Oncology. 2020;152:S507-S8.
  84. Hosseini S, Hasanzadeh Mofrad M, Aghel E, Homaei Shandiz F, Yousofi Z, Shahid Sales S, et al. Treatment complication, pathologic response and survival rate after chemotherapy before surgery in locally advanced cervical cancer. The Iranian Journal of Obstetrics, Gynecology and Infertility. 2020;22(12):1-10.
  85. Hoseini SS, Yousefi Z, Emadzadeh M, Homaee Shandiz F, Hokmabadi P, Salehi M, et al. Changes in prevalence and epidemiology of female genital cancers in northeastern Iran in a 35-year study. The Iranian Journal of Obstetrics, Gynecology and Infertility. 2020;22(12):11-8.
  86. Homaei Shandiz F, Fanipakdel A, Forghani MN, Javadinia SA, Mousapour Shahi E, Keramati A, et al. Clinical Efficacy and Side Effects of IORT as Tumor Bed Boost During Breast-Conserving Surgery in Breast Cancer Patients Following Neoadjuvant Chemotherapy. Indian Journal of Gynecologic Oncology. 2020;18(2).
  87. Hassanzadeh M, Jafarian AH, Homaee F, Jeddi L, Malakuti P, MOUSAVI SL. Diagnostic error, benign infiltrative pseudotumor or malignant primary lymphoma of cervix: case report. 2020.
  88. Hassani S, Afkhamizadeh M, Teimouri A, Najafi MN, Mostaan LV, Mohebbi M. Evaluation of serum level of FGF23 and 1,25(OH)2D3 in primary hyperparathyroidism patients before and after parathyroidectomy. International Journal of General Medicine. 2020;13:289-95.
  89. Ghorbani M, Azizi M, Azadegan B, Mowlavi AA, Rahvar ZA, Wagner W. Dosimetric evaluation of neutron contamination caused by dental restorations during photon radiotherapy with a 15 MV Siemens Primus linear accelerator. Radiation Physics and Chemistry. 2020;174.
  90. G Motlagh A, Mofid B, Salek R, Hemati S, Mosalaei A, Esnaashari O, et al. Evaluation of Clinical and Pathological Characteristics and Routine Treatment of Patients with Prostate Cancer in Six Referral Centers in Iran: A Pilot Non-interventional, Multicenter Study. Reports of Radiotherapy and Oncology. 2020;7(1).
  91. Fazilat-Panah D, Roudi SVA, Keramati A, Fanipakdel A, Sadeghian MH, Shandiz FH, et al. Changes in Cytokeratin 18 during Neoadjuvant Chemotherapy of Breast Cancer: A Prospective Study. Iranian journal of pathology. 2020;15(2):117.
  92. Farazestanian M, Rakhshanifar M, Yousefi Z, Hasanzadeh M, Homaee F, Jafarian AH, et al. Primary ovarian non-Hodgkin's lymphoma: a case report. The Iranian Journal of Obstetrics, Gynecology and Infertility. 2020;23(9):108-12.
  93. Farahmandfar F, Shakeri S, Askari E, Jafarian AH, Jamshidi ST, Shafiei S, et al. Parotid metastasis as the first presentation of papillary thyroid carcinoma. Iranian Journal of Nuclear Medicine. 2020;28(2):42-5.
  94. Eskandari A, Nasseri S, Gholamhosseinian H, Hosseini S, Farzaneh MJK, Keramati A, et al. Evaluation of the heart and lung dosimetric parameters in deep inspiration breath hold using 3D slicer. Radiation Oncology Journal. 2020;38(1):68-76.
  95. Dalirsani Z, Memar B, Pakfetrat A, Mohtasham N, Anvari K, Kaveh S. Epidermal growth factor receptor expression in oral squamous cell carcinoma by immunohistochemical technique and its correlation with clinicopathological features. Journal of Kerman University of Medical Sciences. 2020;27(4):283-93.
  96. Arianpoor A, Asadi M, Amini E, Ziaeemehr A, Ahmadi Simab S, Zakavi SR. Investigating the prevalence of risk factors of papillary thyroid carcinoma recurrence and disease-free survival after thyroidectomy and central neck dissection in Iranian patients. Acta Chirurgica Belgica. 2020;120(3):173-8.
  97. Alizadeh Rahvar Z, Ghorbani M, Khosroabadi M, Knaup C. Radiation Shielding Materials: Half-value layer determination for separate and simultaneous photon and neutron emissions by a 252Cf source. International Journal of Radiation Research. 2020;18(2):381-7.
  98. Afzaljavan F, Moezzi A, Vahednia E, Shamshiri AK, Vakili F, Shandiz FH, et al. Predictive and prognostic value of LSP1 rs3817198 in sporadic breast cancer in northeastern population of Iran. Experimental and molecular pathology. 2020;116:104514.
  99. Afzaljavan F, Moezzi A, Vahednia E, Khorshid Shamshiri A, Vakili F, Homaei Shandiz F, et al. Predictive and prognostic value of LSP1 rs3817198 in sporadic breast cancer in northeastern population of Iran. Experimental and Molecular Pathology. 2020;116.
  100. Abdeahad H, Bahrami A, Khazaei M, Ferns GA, Erfani M, Fiuji H, et al. Clinical association between phospho-akt expression with clinicopathological characteristics of gastrointestinal cancer patients: A meta-analysis. Critical Reviews in Eukaryotic Gene Expression. 2020;30(4):299-309.
  101. Ziaeemehr A, Shahidsales S, Ghosi Z, Avan A, Aldavood AS, Anvari K, et al. Association of the involvement of axillary lymph nodes in HER-2/neu overexpression in patients with breast cancer. Breast Journal. 2019;25(3):537-8.
  102. Yaghoubi A, Khazaei M, Hasanian SM, Avan A, Cho WC, Soleimanpour S. Bacteriotherapy in breast cancer. International Journal of Molecular Sciences. 2019;20(23).
  103. Vahednia E, Shandiz FH, Bagherabad MB, Moezzi A, Afzaljavan F, Tajbakhsh A, et al. The Impact of CASP8 rs10931936 and rs1045485 Polymorphisms as well as the Haplotypes on Breast Cancer Risk: A Case-Control Study. Clinical Breast Cancer. 2019;19(5):e563-e77.
  104. Tavakkol Afshari Z, Gholizadeh Z, Nikpoor AR, Tavakkol Afshari J, Ganjali R, Homaei Shandiz F, et al. A case-control study on the p73 G4A gene polymorphism and susceptibility to breast cancer in an iranian population. Iranian Journal of Public Health. 2019;48(10):1855-60.
  105. Tajbakhsh A, Javan FA, Rivandi M, Moezzi A, Abedini S, Asghari M, et al. Significant association of TOX3/LOC643714 locus-rs3803662 and breast cancer risk in a cohort of Iranian population. Molecular biology reports. 2019;46(1):805-11.
  106. Taghizadeh Kermani A, Hosseini S, Fanipakdel A, Joudi Mashhad M, Akhavan Rezayat K, Zardadi M, et al. A randomized clinical trial on the antitumoral effects of low molecular weight heparin in the treatment of esophageal cancer. Journal of Cellular Physiology. 2019;234(4):4191-9.
  107. Taghizadeh A, Pourali L, Joudi M, Salehi M, Eshghi S, Torabian F, et al. Assessment of elevated serum tumor markers carcinoembryonic antigen (CEA) and cancer antigen 15-3 (CA15-3) among patients with different subtypes of metastatic breast cancer. Middle East Journal of Cancer. 2019;10(1):17-22.
  108. Shandiz FH, Afzaljavan F, Hosseinzadeh L, Moezzi A, Pasdar A. The impact of Zinc Finger 365 Polymorphisms and haplotypes on breast cancer risk in an Iranian population. The Breast. 2019;44:S39.
  109. Salek M, Salek R. Esophageal Cancer in Khorasan, Iran. Razavi International Journal of Medicine. 2019;7(1):37-9.
  110. Rivandi M, Pasdar A, Hamzezadeh L, Tajbakhsh A, Seifi S, Moetamani-Ahmadi M, et al. The prognostic and therapeutic values of long noncoding RNA PANDAR in colorectal cancer. Journal of Cellular Physiology. 2019;234(2):1230-6.
  111. Rastgar-Moghadam A, Mehramiz M, Shahidsales S, Entezari M, Hassanian SM, Talebian S, et al. Association of a genetic variant in ATP-binding cassette sub-family B member 1 gene with poor prognosis in patients with squamous cell carcinoma of the esophagus. IUBMB Life. 2019;71(9):1252-8.
  112. Rahmani F, Amerizadeh F, Hassanian SM, Hashemzehi M, Nasiri SN, Fiuji H, et al. PNU-74654 enhances the antiproliferative effects of 5-FU in breast cancer and antagonizes thrombin-induced cell growth via the Wnt pathway. Journal of Cellular Physiology. 2019;234(8):14123-32.
  113. Radmanesh H, Sadr-Nabavi A, Shandiz FH, Khales SA, Park-Simon T, Hillemanns P, et al., editors. Digenic inheritance of RASSF1A and KLK3 mutations in an Iranian multiple-case breast cancer family. EUROPEAN JOURNAL OF HUMAN GENETICS; 2019: NATURE PUBLISHING GROUP MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND.
  114. Parizadeh SM, Parizadeh SA, Alizade-Noghani M, Jafarzadeh-Esfehani R, Ghandehari M, Mottaghi-Moghaddam A, et al. Association between non-alcoholic fatty liver disease and colorectal cancer. Expert Review of Gastroenterology and Hepatology. 2019;13(7):633-41.
  115. Parizadeh SM, Jafarzadeh-Esfehani R, Hassanian SM, Parizadeh SMR, Vojdani S, Ghandehari M, et al. Targeting cancer stem cells as therapeutic approach in the treatment of colorectal cancer. International Journal of Biochemistry and Cell Biology. 2019;110:75-83.
  116. Parizadeh SM, Jafarzadeh-Esfehani R, Hassanian SM, Mottaghi-Moghaddam A, Ghazaghi A, Ghandehari M, et al. Vitamin D in inflammatory bowel disease: From biology to clinical implications. Complementary Therapies in Medicine. 2019;47.
  117. Parizadeh SM, Jafarzadeh-Esfehani R, Ghandehari M, Rezaei-Kalat A, Parizadeh SMR, Javanbakht A, et al. Personalized peptide-based vaccination for treatment of colorectal cancer: Rational and progress. Current Drug Targets. 2019;20(14):1486-95.
  118. Parizadeh SM, Jafarzadeh-Esfehani R, Ghandehari M, Hasanzadeh M, Parizadeh SMR, Hassanian SM, et al. Circulating and tissue microRNAs as biomarkers for ovarian cancer prognosis. Current Drug Targets. 2019;20(14):1447-60.
  119. Parizadeh SM, Jafarzadeh-Esfehani R, Fazilat-Panah D, Hassanian SM, Shahidsales S, Khazaei M, et al. The potential therapeutic and prognostic impacts of the c-MET/HGF signaling pathway in colorectal cancer. IUBMB Life. 2019;71(7):802-11.
  120. Nasiri N, Avan A, Hassanian SM, Khazaei M. Effect of anti-angiogenic drugs along with chemotherapy in breast cancer treatment: Review article. Iranian Journal of Obstetrics, Gynecology and Infertility. 2019;22(5):78-89.
  121. Mostaan LV, Haghjoo S, Anvari K, Safarian M, Khazaeni K, Aghaei MA. Studying Malnutrition-Related Factors in Patients with Head and Neck Cancer Following Surgery. Journal of Hearing Sciences and Otolaryngology. 2019;5(2):1-8.
  122. Moradzadeh M, Kalani MR, Avan A. The antileukemic effects of saffron (Crocus sativus L.) and its related molecular targets: A mini review. Journal of Cellular Biochemistry. 2019;120(4):4732-8.
  123. Moradi-Marjaneh R, Hassanian SM, Mehramiz M, Rezayi M, Ferns GA, Khazaei M, et al. Reactive oxygen species in colorectal cancer: The therapeutic impact and its potential roles in tumor progression via perturbation of cellular and physiological dysregulated pathways. Journal of Cellular Physiology. 2019;234(7):10072-9.
  124. Mohammadpur S, Yousefi M, Ebrahimipur H, Harati-Khalilabad T, Hagjighat H, Kiani MM, et al. The Direct Medical Care Costs Associated with Gastric Cancer in a Third-level Hospital in Iran. Basic & Clinical Cancer Research. 2019;11(1):45-54.
  125. Moghbeli M, Makhdoumi Y, Soltani Delgosha M, Aarabi A, Dadkhah E, Memar B, et al. ErbB1 and ErbB3 co-over expression as a prognostic factor in gastric cancer. Biological research. 2019;52(1):2.
  126. Mahdavi M, Nassiri M, Kooshyar MM, Vakili-Azghandi M, Avan A, Sandry R, et al. Hereditary breast cancer; Genetic penetrance and current status with BRCA. Journal of Cellular Physiology. 2019;234(5):5741-50.
  127. Kooshyar MM, Maruzi A, Pakdel AF, Elyasi S, Taghizadeh-Kermani A, Akbarzadeh M, et al. Adherence to a standardized chemotherapy order form for colorectal cancer in a referral teaching hospital, Mashhad, Iran. Iranian Journal of Pharmaceutical Research. 2019;18(1):488-95.
  128. Kermani AT, Bagheri R, Taheri H, Aliakbarian M, Soltani E, Joudi M. Evaluation of survival and recurrence patterns in esophageal cancer patients with pathological response to neoadjuvant chemoradiotherapy. Kardiochirurgia i Torakochirurgia Polska. 2019;16(4):186-93.
  129. Karbasforooshan H, Hosseini S, Elyasi S, Fani Pakdel A, Karimi G. Topical silymarin administration for prevention of acute radiodermatitis in breast cancer patients: A randomized, double-blind, placebo-controlled clinical trial. Phytotherapy Research. 2019;33(2):379-86.
  130. Joodi M, Amerizadeh F, Hassanian SM, Erfani M, Ghayour-Mobarhan M, Ferns GA, et al. The genetic factors contributing to hypospadias and their clinical utility in its diagnosis. Journal of Cellular Physiology. 2019;234(5):5519-23.
  131. Javadinia SA, Shahidsales S, Fanipakdel A, Joudi-Mashhad M, Mehramiz M, Talebian S, et al. Therapeutic potential of targeting the Wnt/β-catenin pathway in the treatment of pancreatic cancer. Journal of Cellular Biochemistry. 2019;120(5):6833-40.
  132. Hosseini S, Shahabadi M, Salek R, Fanipakdel A, Ghofraniha L, Ghaderi F, et al. Accelerated hypofractionated whole breast radiotherapy for early breast cancer; a randomized phase III clinical trial. Acta Medica Iranica. 2019:645-52.
  133. Hosseini S, Nguyen NP, Mohammadianpanah M, Mirzaei S, Bananzadeh AM. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study. Journal of Gastrointestinal Cancer. 2019;50(4):716-22.
  134. Hosseini S, Chamani J, Sinichi M, Bonakdar AM, Azad Z, Ahangari N, et al. The effect of nanomicelle curcumin, sorafenib, and combination of the two on the cyclin D1 gene expression of the hepatocellular carcinoma cell line (HUH7). Iranian Journal of Basic Medical Sciences. 2019;22(10):1198-202.
  135. Hosseini S, Chamani J, Hadipanah MR, Ebadpour N, Hojjati AS, Mohammadzadeh MH, et al. Nano-curcumin’s suppression of breast cancer cells (MCF7) through the inhibition of cyclinD1 expression. Breast Cancer: Targets and Therapy. 2019;11:137-42.
  136. Hashemi SM, Ramroodi N, Fard HA, Talebian S, Rohani MH, Rezaei M, et al. Common variations in prothrombotic genes and susceptibility to ischemic stroke in young patients: A case-control study in southeast Iran. Medicina (Lithuania). 2019;55(2).
  137. Hashemi S, Bahreyni M, Mohammadi M, Nasseri S, Bayani S, Gholamhosseinian H, et al. An empirical transmitted epid dosimetry method using a back-projection algorithm. Journal of biomedical physics & engineering. 2019;9(5):551.
  138. Hasanzadeh M, Movahedi M, Rejali M, Maleki F, Moetamani-Ahmadi M, Seifi S, et al. The potential prognostic and therapeutic application of tissue and circulating microRNAs in cervical cancer. Journal of Cellular Physiology. 2019;234(2):1289-94.
  139. Hamzian N, Hashemi M, Ghorbani M, Aledavood SA, Ramezani M, Toosi MHB. In-vitro study of multifunctional plga-spion nanoparticles loaded with gemcitabine as radiosensitizer used in radiotherapy. Iranian Journal of Pharmaceutical Research. 2019;18(4):1694-703.
  140. Ghobadi N, Mehramiz M, ShahidSales S, Rezaei Brojerdi A, Anvari K, Khazaei M, et al. A genetic variant in CDKN2A/2B locus was associated with poor prognosis in patients with esophageal squamous cell carcinoma. Journal of Cellular Physiology. 2019;234(4):5070-6.
  141. Ghanaatgar-Kasbi S, Amerizadeh F, Rahmani F, Hassanian SM, Khazaei M, Ferns GA, et al. AMP-kinase inhibitor dorsomorphin reduces the proliferation and migration behavior of colorectal cancer cells by targeting the AKT/mTOR pathway. IUBMB Life. 2019;71(12):1929-36.
  142. Ghafarian F, Pashirzad M, Khazaei M, Rezayi M, Hassanian SM, Ferns GA, et al. The clinical impact of exosomes in cardiovascular disorders: From basic science to clinical application. Journal of Cellular Physiology. 2019;234(8):12226-36.
  143. Gachpazan M, Kashani H, Khazaei M, Hassanian SM, Rezayi M, Asgharzadeh F, et al. The impact of statin therapy on the survival of patients with gastrointestinal cancer. Current Drug Targets. 2019;20(7):738-47.
  144. Fanipakdel A, Seilanian Toussi M, Rezazadeh F, Mohamadian Roshan N, Javadinia SA. Overexpression of cancer-testis antigen melanoma-associated antigen A1 in lung cancer: A novel biomarker for prognosis, and a possible target for immunotherapy. Journal of Cellular Physiology. 2019;234(7):12080-6.
  145. Fanipakdel A, Hosseini A, Afshar ST, Nourbakhsh M, Mousavi SH. Cytotoxic effects and radiosensitizing potential of Artemisia kopetdaghensis extract in human cervical cancel HeLa cells. Electronic Physician. 2019;11(3).
  146. Ehsani O, Pouladian M, Toosizadeh S, Aledavood A. Registration and fusion of 3D surface data from CT and ToF camera for position verification in radiotherapy. SN Applied Sciences. 2019;1(11):1-12.
  147. Delavarian Z, Pakfetrat A, Ghazi A, Jaafari MR, Homaei Shandiz F, Dalirsani Z, et al. Oral administration of nanomicelle curcumin in the prevention of radiotherapy-induced mucositis in head and neck cancers. Special Care in Dentistry. 2019;39(2):166-72.
  148. Danaei GH, Memar B, Ataee R, Karami M. Protective effect of thymoquinone, the main component of Nigella Sativa, against diazinon cardio-toxicity in rats. Drug and Chemical Toxicology. 2019;42(6):585-91.
  149. Dalirsani Z, Pakfetrat A, Delavarian Z, Hashemy SI, Mostaan LV, Abdollahnejad M, et al. Comparison of matrix metalloproteinases 2 and 9 levels in saliva and serum of patients with head and neck squamous cell carcinoma and healthy subjects. International Journal of Cancer Management. 2019;12(5).
  150. Baziar O, Gholamhosseinian H, Anvari K. Dose Distribution Evaluation and Independent Quality Check of Spherical INTRABEAMâ ¢ Applicators via Radiochromic EBT2 Film Measurement. Iranian Journal of Medical Physics. 2019;16(2):145-51.
  151. Barati Bagherabad M, Afzaljavan F, ShahidSales S, Hassanian SM, Avan A. Targeted therapies in pancreatic cancer: Promises and failures. Journal of Cellular Biochemistry. 2019;120(3):2726-41.
  152. Bakhshizadeh M, Mohajeri SA, Esmaily H, Aledavood SA, Varshoei Tabrizi F, Seifi M, et al. Utilizing photosensitizing and radiosensitizing properties of TiO 2 -based mitoxantrone imprinted nanopolymer in fibrosarcoma and melanoma cells. Photodiagnosis and Photodynamic Therapy. 2019;25:472-9.
  153. Bahri N, Najafi TF, Shandiz FH, Tohidinik HR, Khajavi A. The relation between stressful life events and breast cancer: a systematic review and meta-analysis of cohort studies. Breast cancer research and treatment. 2019;176(1):53-61.
  154. Bagherabad MB, Afzaljavan F, Vahednia E, Rivandi M, Vakili F, Sadr SSH, et al. Association of caspase 8 promoter variants and haplotypes with the risk of breast cancer and its molecular profile in an Iranian population: A case‐control study. Journal of cellular biochemistry. 2019;120(10):16435-44.
  155. Babapour N, Mehramiz M, Rastgar Moghadam A, Behboodi N, Yousefi Z, Maftouh M, et al. Association of TNF-308 G>A polymorphism located in tumor necrosis factor a with the risk of developing cervical cancer and results of pap smear. Journal of Cellular Biochemistry. 2019;120(4):5444-8.
  156. Amerizadeh F, Bahrami A, Khazaei M, Hesari A, Rezayi M, Talebian S, et al. Current status and future prospects of transforming growth factor-β as a potential prognostic and therapeutic target in the treatment of breast cancer. Journal of Cellular Biochemistry. 2019;120(5):6962-71.
  157. Aghaei A, Aryana K, Salek R, Zakavi SR, Ahmadzadefar H. Meningioma: A false positive finding of metastasis from prostate adenocarcinoma using 68Ga-PSMA PET/CT scan. Iranian Journal of Nuclear Medicine. 2019;27(1):53-6.
  158. Zanguie M, Abdollahi A, Salek R, Jangjoo A, Jabbari Nooghabi M, Shabahang H, et al. Three Anastomotic Techniques Following Laparoscopic Rectal Cancer Resection: Our Experience in 155 Patients. Surgical Innovation. 2018;25(1):57-61.
  159. Tajbakhsh A, Hasanzadeh M, Rezaee M, Khedri M, Khazaei M, ShahidSales S, et al. Therapeutic potential of novel formulated forms of curcumin in the treatment of breast cancer by the targeting of cellular and physiological dysregulated pathways. Journal of Cellular Physiology. 2018;233(3):2183-92.
  160. Taghizadeh A, Pourali L, Vaziri Z, Saedi HR, Behdani F, Amel R. Psychological distress in cancer patients. Middle East Journal of Cancer. 2018;9(2):143-9.
  161. Shahrabi-Farahani M, Karimi E, Mostaan LV, Saba S, Yazdani N, M.Amoli M. Association between epstein barr virus and tongue squamous cell carcinoma in iranian patients. Pathology Research and Practice. 2018;214(1):130-3.
  162. ShahidSales S, Mehramiz M, Ghasemi F, Aledavood A, Shamsi M, Hassanian SM, et al. A genetic variant in CDKN2A/B gene is associated with the increased risk of breast cancer. Journal of Clinical Laboratory Analysis. 2018;32(1).
  163. Shahidsales S, Joudi M, Mirsadraee M, Avan A, Simab SA, Ghavamnasiri MR. Clinicopathologic features and survival of breast cancer subtypes in northeast Iran. Middle East Journal of Cancer. 2018;9(1):27-33.
  164. Sadrizadeh A, Bagheri R, Soltani E, Anvari K, Toussi MS, Moadikhah S. The Comparison of the Advantages of Neoadjuvant Chemoradiotherapy versus Postoperative Chemoradiotherapy: Outcomes in Esophageal Cancer Patients. Journal of Gastrointestinal Cancer. 2018;49(1):50-6.
  165. Rouhani M, Mousavi M, Kooshyar MM, Shahidsales S, Makhdoumi Y, Amirabadi A, et al. Application of a chemotherapy standard form in patients with breast cancer: Comparison of private and public centers. Jundishapur Journal of Natural Pharmaceutical Products. 2018;13(3).
  166. Rivandi M, Khorrami MS, Fiuji H, Shahidsales S, Hasanzadeh M, Jazayeri MH, et al. The 9p21 locus: A potential therapeutic target and prognostic marker in breast cancer. Journal of Cellular Physiology. 2018;233(7):5170-9.
  167. Rezaei N, Hassanian SM, Avan A, Khazaei M. Clinical studies on the effect of saffron in different diseases. Journal of Isfahan Medical School. 2018;35(456):1690-9.
  168. Rahmani F, Avan A, Hashemy SI, Hassanian SM. Role of Wnt/β-catenin signaling regulatory microRNAs in the pathogenesis of colorectal cancer. Journal of Cellular Physiology. 2018;233(2):811-7.
  169. Rafeemanesh E, Taghizadeh Kermani A, Khajedaluee M, Ahmadi F. Evaluation of breast cancer risk in relation to occupation. Middle East Journal of Cancer. 2018;9(3):186-94.
  170. Pouya F, Mojtabanezhad Shariatpanahi A, Ghaffarzadegan K, Tabatabaee Yazdi SA, Golmohammadzadeh H, Soltani G, et al. A novel large germ line deletion in adenomatous polyposis coli (APC) gene associated with familial adenomatous polyposis. Molecular Genetics and Genomic Medicine. 2018;6(6):1031-40.
  171. Pourali L, Shahid Sales S, Taghizadeh A, Pezeshkirad M, Farokh D, Andakhshideh E. Mammographic findings in different breast cancer subtypes (luminal, Her2 positive, triple negative). International Journal of Radiation Research. 2018;16(2):251-5.
  172. Pour AS, Pourali L, Joudi M, Taghizadeh A, Salehi M, Gazanchian M, et al. Different breast cancer subtypes in women more than 65-year-old. Acta Medica Iranica. 2018:698-703.
  173. Parizadeh SM, Jafarzadeh-Esfehani R, Ghandehari M, Seifi S, Parizadeh SMR, Moetamani-Ahmadi M, et al. Epigenetic Drug Therapy in the Treatment of Colorectal Cancer. Current pharmaceutical design. 2018;24(23):2701-9.
  174. Najaf Najafi M, Salehi M, Ghazanfarpour M, Hoseini ZS, Khadem-Rezaiyan M. The association between green tea consumption and breast cancer risk: A systematic review and meta-analysis. Phytotherapy Research. 2018;32(10):1855-64.
  175. Moradi-Marjaneh R, Khazaei M, Seifi S, Hassanian SM, Ferns GA, Avan A. Pharmacogenetics of Anticancer Drug Sensitivity and Toxicity in Colorectal Cancer. Current pharmaceutical design. 2018;24(23):2710-8.
  176. Moradi-Marjaneh R, Hassanian SM, Fiuji H, Soleimanpour S, Ferns GA, Avan A, et al. Toll like receptor signaling pathway as a potential therapeutic target in colorectal cancer. Journal of Cellular Physiology. 2018;233(8):5613-22.
  177. Moradi Marjaneh R, Hassanian SM, Ghobadi N, Ferns GA, Karimi A, Jazayeri MH, et al. Targeting the death receptor signaling pathway as a potential therapeutic target in the treatment of colorectal cancer. Journal of Cellular Physiology. 2018;233(10):6538-49.
  178. Moradi A, Ghasemi F, Anvari K, Simab SA, Hassanian SM, Ebrahimi S, et al. Association of epstein-barr virus with esophageal squamous cell carcinoma. Middle East Journal of Cancer. 2018;9(2):91-7.
  179. Moghadam AR, Mehramiz M, Entezari M, Aboutalebi H, Kohansal F, Dadjoo P, et al. A genetic polymorphism in the CYP1B1 gene in patients with squamous cell carcinoma of the esophagus: An Iranian Mashhad cohort study recruited over 10 years. Pharmacogenomics. 2018;19(6):539-46.
  180. Marjaneh RM, Rahmani F, Hassanian SM, Rezaei N, Hashemzehi M, Bahrami A, et al. Phytosomal curcumin inhibits tumor growth in colitis-associated colorectal cancer. Journal of Cellular Physiology. 2018;233(10):6785-98.
  181. Keramati A, Homaei Shandiz F, Taghizadeh-Hesary F, Gharib M. Metaplastic breast carcinoma with osseous remnant post standard treatment of invasive ductal carcinoma: Case report and review of the literature. European Journal of Oncology. 2018;23(1):52-6.
  182. Karimi G, Hassanzadeh-Josan S, Memar B, Esmaeili SA, Riahi-Zanjani B. Immunomodulatory effects of silymarin after subacute exposure to mice: A tiered approach immunotoxicity screening. Journal of Pharmacopuncture. 2018;21(2):90-7.
  183. Javid H, Hashemy I, Shahidsales S, Mohammadian Roshan N, Kianoosh T, Zahedi Avval F. Tissue Expression of Prohibition-I and It's Relationship With Prognostic Factors in Breast Cancer. Iran J Pathol. 2018;13(2):237-44.
  184. Javadinia SA, Shahidsales S, Fanipakdel A, Mostafapour A, Joudi-Mashhad M, Ferns GA, et al. The esophageal cancer and the PI3K/AKT/mTOR signaling regulatory microRNAs: A novel marker for prognosis, and a possible target for immunotherapy. Current Pharmaceutical Design. 2018;24(39):4646-51.
  185. Javadinia SA, Gholami A, Joudi Mashhad M, Ferns GA, Shahidsales S, Avan A, et al. Anti‐tumoral effects of low molecular weight heparins: A focus on the treatment of esophageal cancer. Journal of cellular physiology. 2018;233(10):6523-9.
  186. Javadinia SA, Gholami A, Joudi Mashhad M, Ferns GA, Shahidsales S, Avan A, et al. Anti-tumoral effects of low molecular weight heparins: A focus on the treatment of esophageal cancer. Journal of Cellular Physiology. 2018;233(10):6523-9.
  187. Jalalabadi Y, Shirazi A, Ghavam-Nasiri MR, Aledavood S, Sardari D, Memar B, et al. Evaluating the expression of cyclooxygenase-2 enzyme by immunohistochemistry in normal and tumoral tissue before and after neoadjuvant chemoradiotherapy in patients with esophageal cancer in Khorasan Province. Journal of Cancer Research and Therapeutics. 2018;14(3):509-15.
  188. Imanparast A, Bakhshizadeh M, Salek R, Sazgarnia A. Pegylated hollow gold-mitoxantrone nanoparticles combining photodynamic therapy and chemotherapy of cancer cells. Photodiagnosis and Photodynamic Therapy. 2018;23:295-305.
  189. Hosseini S, Chamani J, Rahimi H, Azmoodeh N, Ghasemi F, Abadi PH. An in vitro study on curcumin delivery by nano-micelles for esophageal squamous cell carcinoma (KYSE-30). Reports of Biochemistry and Molecular Biology. 2018;6(2):137-43.
  190. Hosseini S, Bananzadeh AM, Mohammadianpanah M, Salek R, Taghizadeh-Kermani A. Prognostic significance of adjuvant radiation therapy in adenocarcinoma of the cecum. Radiation Oncology Journal. 2018;36(1):45-53.
  191. Hesari A, Golrokh Moghadam SA, Siasi A, Rahmani M, Behboodi N, Rastgar-Moghadam A, et al. Tumor-derived exosomes: Potential biomarker or therapeutic target in breast cancer? Journal of Cellular Biochemistry. 2018;119(6):4236-40.
  192. Hashemzehi M, Behnam-Rassouli R, Hassanian SM, Moradi-Binabaj M, Moradi-Marjaneh R, Rahmani F, et al. Phytosomal-curcumin antagonizes cell growth and migration, induced by thrombin through AMP-Kinase in breast cancer. Journal of Cellular Biochemistry. 2018;119(7):5996-6007.
  193. Hashemzehi M, Avan A, Hasanzadeh M, Sales SS, Yousefi Z, Kadkhodayan S, et al. Effects of the novel formulated forms of curcumin on tumor growth inhibition in breast cancer. Iranian Journal of Obstetrics, Gynecology and Infertility. 2018;21(2):75-84.
  194. Gholoobi A, Abnous K, Ramezani M, Homaei Shandiz F, Darroudi M, Ghayour-Mobarhan M, et al. Synthesis of γ-Fe2O3 Nanoparticles Capped with Oleic Acid and their Magnetic Characterization. Iranian Journal of Science and Technology, Transaction A: Science. 2018;42(4):1889-93.
  195. Gholamin S, Mirzaei H, Razavi SM, Hassanian SM, Saadatpour L, Masoudifar A, et al. GD2-targeted immunotherapy and potential value of circulating microRNAs in neuroblastoma. Journal of Cellular Physiology. 2018;233(2):866-79.
  196. Ghanaatgar-Kasbi S, Khorrami S, Avan A, Aledavoud SA, Ferns GA. Targeting the c-MET/HGF signaling pathway in pancreatic ductal adenocarcinoma. Current pharmaceutical design. 2018;24(39):4619-25.
  197. Forouzmand SH, Mousavi SH, Vazifedan V, Nourbakhsh M, Chamani J, Hoseini A, et al. Synergistic effects of Ferula gummosa and radiotherapy on induction of cytotoxicity in HeLa cell line. Avicenna journal of phytomedicine. 2018;8(5):439.
  198. Fanipakdel A, Davoudi Y, Javadinia SA, Seilanian Toussi M. Pathologic fracture as primary presentation of malignant pheochromocytoma: A case report. Acta Medica Iranica. 2018;56(12):803-6.
  199. Dehnavi Z, Razmpour F, Naseri MB, Nematy M, Alamdaran SA, Vatanparast HA, et al. Fatty liver index (FLI) in predicting non-alcoholic fatty liver disease (NAFLD). Hepatitis Monthly. 2018;18(2).
  200. Boromand N, Hasanzadeh M, ShahidSales S, Farazestanian M, Gharib M, Fiuji H, et al. Clinical and prognostic value of the C-Met/HGF signaling pathway in cervical cancer. Journal of Cellular Physiology. 2018;233(6):4490-6.
  201. Bitaraf SM, Mahmoudian RA, Abbaszadegan M, Meybodi AM, Taghehchian N, Mansouri A, et al. Association of two CD44 polymorphisms with clinical outcomes of gastric cancer patients. Asian Pacific Journal of Cancer Prevention. 2018;19(5):1313-8.
  202. Binabaj MM, Bahrami A, ShahidSales S, Joodi M, Joudi Mashhad M, Hassanian SM, et al. The prognostic value of MGMT promoter methylation in glioblastoma: A meta-analysis of clinical trials. Journal of Cellular Physiology. 2018;233(1):378-86.
  203. Beheshti F, Hassanian SM, Khazaei M, Hosseini M, ShahidSales S, Hasanzadeh M, et al. Genetic variation in the DNA repair pathway as a potential determinant of response to platinum-based chemotherapy in breast cancer. Journal of Cellular Physiology. 2018;233(4):2752-8.
  204. Bahrami A, Khazaei M, Shahidsales S, Hassanian SM, Hasanzadeh M, Maftouh M, et al. The Therapeutic Potential of PI3K/Akt/mTOR Inhibitors in Breast Cancer: Rational and Progress. Journal of Cellular Biochemistry. 2018;119(1):213-22.
  205. Bahrami A, Khazaei M, Hassanian SM, ShahidSales S, Joudi-Mashhad M, Maftouh M, et al. Targeting the tumor microenvironment as a potential therapeutic approach in colorectal cancer: Rational and progress. J Cell Physiol. 2018;233(4):2928-36.
  206. Bahrami A, Khazaei M, Hasanzadeh M, ShahidSales S, Joudi Mashhad M, Farazestanian M, et al. Therapeutic Potential of Targeting PI3K/AKT Pathway in Treatment of Colorectal Cancer: Rational and Progress. Journal of Cellular Biochemistry. 2018;119(3):2460-9.
  207. Bahrami A, Joodi M, Maftooh M, Ferns GA, Ahmadi MM, Hassanian SM, et al. The genetic factors contributing to the development of wilm’s tumor and their clinical utility in its diagnosis and prognosis. Journal of Cellular Physiology. 2018;233(4):2882-8.
  208. Bahrami A, Hesari AR, Khazaei M, Hassanian SM, Ferns GA, Avan A. The therapeutic potential of targeting the BRAF mutation in patients with colorectal cancer. Journal of Cellular Physiology. 2018;233(3):2162-9.
  209. Bahrami A, Hassanian SM, ShahidSales S, Farjami Z, Hasanzadeh M, Anvari K, et al. Targeting RAS signaling pathway as a potential therapeutic target in the treatment of colorectal cancer. Journal of Cellular Physiology. 2018;233(3):2058-66.
  210. Bahrami A, Hassanian SM, Khazaei M, Hasanzadeh M, Shahidsales S, Maftouh M, et al. The Therapeutic Potential of Targeting Tumor Microenvironment in Breast Cancer: Rational Strategies and Recent Progress. Journal of Cellular Biochemistry. 2018;119(1):111-22.
  211. Bahrami A, Hassanian SM, Khazaei M, Gharib M, Rahmani M, Fiuji H, et al. The 9p21 locus as a potential therapeutic target and prognostic marker in colorectal cancer. Pharmacogenomics. 2018;19(5):463-74.
  212. Bahrami A, Hasanzadeh M, Shahidsales S, Farazestanian M, Hassanian SM, Moetamani Ahmadi M, et al. Genetic susceptibility in cervical cancer: From bench to bedside. Journal of Cellular Physiology. 2018;233(3):1929-39.
  213. Bahrami A, Amerizadeh F, Hassanian SM, ShahidSales S, Khazaei M, Maftouh M, et al. Genetic variants as potential predictive biomarkers in advanced colorectal cancer patients treated with oxaliplatin-based chemotherapy. Journal of Cellular Physiology. 2018;233(3):2193-201.
  214. Bahrami A, Aledavood A, Anvari K, Hassanian SM, Maftouh M, Yaghobzade A, et al. The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs. Journal of Cellular Physiology. 2018;233(2):774-86.
  215. Asli ZN, Nourbakhsh M, Mousavi SH, Pourgonabadi S, Fanipakdel A. Cytotoxicity and radiosensitizing effect of wogonin, an extract from Scutellaria litwinowii, in head and neck squamous cell carcinoma line HN5. Electronic Physician. 2018;10(10).
  216. Asadi-Lari M, Homaee-Shandiz F, Esmaeili-Hesari A. Changes in health-related quality of life in oesophagogastric cancer patients participating in palliative and curative therapies. Medical Journal of the Islamic Republic of Iran. 2018;32(1):182-90.
  217. Asadi M, Ziaeemehr A, Shahidsales S, Aledavood SA, Anvari K, Mirsadraee M, et al. Evaluation of involvement of axillary lymph nodes with Ki-67 expression in patients with breast cancer. International Journal of Cancer Management. 2018;11(8).
  218. Aryana K, Zarehparvar Moghadam S, Salek R, Divband G. 177Lu-Prostate-Specific Membrane Antigen Super Scan and Good Response even after 1 Cycle of Radioligand Therapy. Clinical Nuclear Medicine. 2018;43(4):273-5.
  219. Anvari K, Toussi MS, Ayatollahi H, Bahadorkhan G, Nasiri MG, Ersi MF. Prognostic significance of MGMT promoter methylation in patients with glioblastoma undergoing surgical intervention: A retrospective study in northeastern Iran. Middle East Journal of Cancer. 2018;9(3):179-85.
  220. Anvari K, Toussi MS, Aledavood A, Memar B, Forghani MN, Joudi M. Human epidermal growth factor receptor 2 over-expression in patients with esophageal squamous cell carcinoma; correlation with response to neo-adjuvant chemoradiation and survival. International Journal of Cancer Management. 2018;11(3).
  221. Anvari K, Gharib M, Jafarian AH, Saburi A, Javadinia SA. Primary duodenal malignant melanoma: A case report. Caspian Journal of Internal Medicine. 2018;9(3):312-5.
  222. Anvari K, Dehghan P, Ehsaee MR, Bahadorkhan G. Low back pain and paraplegia as initial clinical presenting of medulloblastoma: A case report. International Journal of Cancer Management. 2018;11(3).
  223. Amerizadeh F, Rezaei N, Rahmani F, Hassanian SM, Moradi-Marjaneh R, Fiuji H, et al. Crocin synergistically enhances the antiproliferative activity of 5-flurouracil through Wnt/PI3K pathway in a mouse model of colitis-associated colorectal cancer. Journal of Cellular Biochemistry. 2018;119(12):10250-61.
  224. Alamdari DH, Asadi M, Rahim AN, Maddah G, Azizi S, Shahidsales S, et al. Efficacy and Safety of Pleurodesis Using Platelet-Rich Plasma and Fibrin Glue in Management of Postoperative Chylothorax After Esophagectomy. World Journal of Surgery. 2018;42(4):1046-55.
  225. Yazdian–Robati R, Ahmadi H, Riahi MM, Lari P, Aledavood SA, Rashedinia M, et al. Comparative proteome analysis of human esophageal cancer and adjacent normal tissues. Iranian Journal of Basic Medical Sciences. 2017;20(3):265-71.
  226. Vaziri ZS, Mashhadi A, Shamloo ZS, Shahidsales S. Mindfulness-based cognitive therapy, cognitive emotion regulation and clinical symptoms in females with breast cancer. Iranian Journal of Psychiatry and Behavioral Sciences. 2017;11(4).
  227. Vazifedan V, Mousavi SH, Sargolzaei J, Soleymanifard S, Pakdel AF. Study of crocin & radiotherapy-induced cytotoxicity and apoptosis in the head and neck cancer (Hn-5) cell line. Iranian Journal of Pharmaceutical Research. 2017;16(1):230-7.
  228. Taghizadeh A, Joudi M, Heriot A, Aliakbarian M, Soltani E, Bagheri R, et al. Patterns of recurrence after complete pathologic response to neoadjuvant chemoradiation in esophageal carcinoma: Report from northeast of Iran. Annals of Oncology. 2017;28:iii27.
  229. Souvizi B, Sales SS, Noferesti GH, Makhdoumi Y, Kalat AR, Esfehani RJ, et al. Assessment of effective factors on prognosis of breast cancer patients. Iranian Journal of Obstetrics, Gynecology and Infertility. 2017;19(39):18-24.
  230. Soleymanifard S, Rostami A, Aledavood SA, Matin MM, Sazgarnia A. Increased radiotoxicity in two cancerous cell lines irradiated by low and high energy photons in the presence of thio-glucose bound gold nanoparticles. International Journal of Radiation Biology. 2017;93(4):407-15.
  231. Sharifi H, Heydari A, Salek R, Zeydi AE. Oral cryotherapy for preventing chemotherapy-induced oral mucositis: An effective but yet neglected strategy. Journal of Cancer Research and Therapeutics. 2017;13(2):386-7.
  232. Shahidsales S, Toussi MS, Joudi M, Gharbi NS, Simab SA, Shahabadi M. Study of clinical characteristics of breast cancer among women older than 70 years. Iranian Journal of Obstetrics, Gynecology and Infertility. 2017;19(38):1-6.
  233. Shafiee M, Mohammadzadeh E, Shahidsales S, Khakpouri S, Maftouh M, Parizadeh SA, et al. Current status and perspectives regarding the therapeutic potential of targeting EGFR pathway by curcumin in lung cancer. Current Pharmaceutical Design. 2017;23(13):2002-8.
  234. Sales SS, Hasanzadeh M, Saggade SS, Al Davoud SA. Comparison of sexual dysfunction in women with breast cancer: Case control study. Tehran University Medical Journal. 2017;75(5):350-7.
  235. Salek R, Tabrizi FV, Ghaffarzadegan K, Sabouri G, Fanipakdel A. A survey in the Basal like breast carcinoma phenotype in north east of Iran. International Journal of Cancer Management. 2017;10(1).
  236. Salek R, Sistani NS, Forghani MN, Ivari MS. Ductal carcinoma in situ within a benign phyllodes tumor of breast: Report of a case. International Journal of Cancer Management. 2017;10(1).
  237. Salehi M, Shojaee P, Shahidsales S, Aledavood SA, Seilaniantoosi M, Goshayeshi G, et al. Epidemiology of primary lung cancer and its trend northeast of Iran during 1985-2012. AACR; 2017.
  238. Radmanesh H, Spethmann T, Enßen J, Schürmann P, Bhuju S, Geffers R, et al. Assessment of an APOBEC3B truncating mutation, c.783delG, in patients with breast cancer. Breast Cancer Research and Treatment. 2017;162(1):31-7.
  239. Pourali L, Taghizadeh A, Akhoundi MR, Varshoei F, Zarifian A, Andalibi MSS. Frequency of chemotherapy induced anemia in breast cancer patients. International Journal of Cancer Management. 2017;10(1).
  240. Pakdel AF, Memar B, Anvari K, Shandiz FH, Ivari MS. Comparison of estrogen, progesterone and her2 receptors in primary breast cancer and paired metastatic lymph nodes: An immunohistochemical study. International Journal of Cancer Management. 2017;10(5).
  241. Oladi M, Sazgarnia A, Nasiri MRG, Amrollahi M, Parhiz H, Ramezani M. In vivo time-dependent radio-protective effect of lycopene against whole-body gamma radiation in mice. Iranian Red Crescent Medical Journal. 2017;19(2).
  242. Moradpoor R, Aledavood SA, Rajabi O, Chamani JK, Sazgarnia A. Enhancement of cisplatin efficacy by gold nanoparticles or microwave hyperthermia? An in vitro study on a melanoma cell line. International Journal of Cancer Management. 2017;10(1).
  243. Moradi-Marjaneh R, Hassanian SM, Avan A, Khazaei M. Role of curcumin in prevention and treatment of colorectal cancer: The mechanisms. Journal of Isfahan Medical School. 2017;35(441):969-77.
  244. Moradi A, Ghasemi F, Anvari K, Hassanian SM, Simab SA, Ebrahimi S, et al. The cross-regulation between SOX15 and Wnt signaling pathway. Journal of Cellular Physiology. 2017;232(12):3221-5.
  245. Mokhtari NB, Salek R, Shandiz FH, Shahidsales SO. Adjuvant chemotherapy of early stage breast cancer in community-based cancer treatment fields: CMF compared with anthracycline/taxane-based regimens. Middle East Journal of Cancer. 2017;8(2):83-91.
  246. Mirzaei H, Ferns GA, Avan A, Mobarhan MG. Cytokines and MicroRNA in Coronary Artery Disease. Advances in Clinical Chemistry: Academic Press Inc.; 2017. p. 47-70.
  247. Maddah G, Abdollahi A, Rouhbakhshfar O, Jamshidi ST, Hassanpour M. Arteriovenous malformations of the colon: A report of two cases and review of the literature. Caspian Journal of Internal Medicine. 2017;8(1):52-5.
  248. Hosseini S, Bananzadeh AM, Salek R, Zare-Bandamiri M, Kermani AT, Mohammadianpanah M. Prognostic significance of Mucinous histologic subtype on oncologic outcomes in patients with colorectal cancer. Annals of Coloproctology. 2017;33(2):57-63.
  249. Hosseini M, Khatamianfar S, Hassanian SM, Nedaeinia R, Shafiee M, Maftouh M, et al. Exosome-encapsulated microRNAs as potential circulating biomarkers in colon cancer. Current Pharmaceutical Design. 2017;23(11):1705-9.
  250. Hosseini M, Hassanian SM, Mohammadzadeh E, ShahidSales S, Maftouh M, Fayazbakhsh H, et al. Therapeutic Potential of Curcumin in Treatment of Pancreatic Cancer: Current Status and Future Perspectives. Journal of Cellular Biochemistry. 2017;118(7):1634-8.
  251. Homaei Shandiz F, Fani A, Shakeri S, Sheikhi M, Ramezani Farkhani A, Shajiei A, et al. Fluorescent in situ hybridization and real-time quantitative polymerase chain reaction to evaluate HER-2/neu status in breast cancer. Iranian Journal of Pathology. 2017;12(1):67-73.
  252. Gholoobi A, Meshkat Z, Abnous K, Ghayour-Mobarhan M, Ramezani M, Homaei Shandiz F, et al. Biopolymer-mediated synthesis of Fe3O4 nanoparticles and investigation of their in vitro cytotoxicity effects. Journal of Molecular Structure. 2017;1141:594-9.
  253. Ghavami V, Mahmoudi M, Foroushani AR, Baghishani H, Shandiz FH, Yaseri M. Long-term disease-free survival of non-metastatic breast cancer patients in Iran: A survival model with competing risks taking cure fraction and frailty into account. Asian Pacific Journal of Cancer Prevention. 2017;18(10):2825-32.
  254. Fathi M, Mohammadi SA, Moslemifar M, Kamali K, Joudi M, Benhangi AS, et al. Hypnoanalgesia for dilatation and curettage pain control. Anesthesiology and pain medicine. 2017;7(2).
  255. Emadzadeh M, Shahidsales S, Mohammadian Bajgiran A, Salehi M, Massoudi T, Nikfarjam Z, et al. Head and Neck Cancers in North-East Iran: A 25 year Survey. Iran J Otorhinolaryngol. 2017;29(92):137-45.
  256. Ebrahimi S, Rahmani F, Behnam-Rassouli R, Hoseinkhani F, Parizadeh MR, Keramati MR, et al. Proinflammatory signaling functions of thrombin in cancer. Journal of Cellular Physiology. 2017;232(9):2323-9.
  257. Ebrahimi S, Jaberi N, Avan A, Ryzhikov M, Keramati MR, Parizadeh MR, et al. Role of thrombin in the pathogenesis of central nervous system inflammatory diseases. Journal of Cellular Physiology. 2017;232(3):482-5.
  258. Ebrahimi S, Hosseini M, Shahidsales S, Maftouh M, Ferns GA, Ghayour-Mobarhan M, et al. Targeting the Akt/PI3K signaling pathway as a potential therapeutic strategy for the treatment of pancreatic cancer. Current Medicinal Chemistry. 2017;24(13):1321-31.
  259. Bezanaj FM, Ivari MS. Cancer, anxiety and distress: Knowledge and attitude. Journal of BUON. 2017;22(2):566.
  260. Bakhshaee M, Raziee HR, Afshari R, Amali A, Roopoosh M, Lotfizadeh A. Opium addiction and risk of laryngeal and esophageal carcinoma. Iranian Journal of Otorhinolaryngology. 2017;29(1):19-22.
  261. Bahreyni-Toosi MH, Zare MH, Ale-Davood A, Shakeri MT, Soudmand S. In-vitro study of photothermal anticancer activity of carboxylated multiwalled carbon nanotubes. Journal of Biomedical Physics and Engineering. 2017;7(4):317-32.
  262. Bahrami A, Shahidsales S, Khazaei M, Ghayour-Mobarhan M, Maftouh M, Hassanian SM, et al. C-Met as a potential target for the treatment of gastrointestinal cancer: Current status and future perspectives. Journal of Cellular Physiology. 2017;232(10):2657-73.
  263. Bahrami A, Khazaei M, Bagherieh F, Ghayour-Mobarhan M, Maftouh M, Hassanian SM, et al. Targeting stroma in pancreatic cancer: Promises and failures of targeted therapies. Journal of Cellular Physiology. 2017;232(11):2931-7.
  264. Bahrami A, Hasanzadeh M, ShahidSales S, Yousefi Z, Kadkhodayan S, Farazestanian M, et al. Clinical Significance and Prognosis Value of Wnt Signaling Pathway in Cervical Cancer. Journal of Cellular Biochemistry. 2017;118(10):3028-33.
  265. Bahrami A, Hasanzadeh M, Hassanian SM, ShahidSales S, Ghayour-Mobarhan M, Ferns GA, et al. The Potential Value of the PI3K/Akt/mTOR Signaling Pathway for Assessing Prognosis in Cervical Cancer and as a Target for Therapy. Journal of Cellular Biochemistry. 2017;118(12):4163-9.
  266. Bahrami A, Amerizadeh F, ShahidSales S, Khazaei M, Ghayour-Mobarhan M, Sadeghnia HR, et al. Therapeutic Potential of Targeting Wnt/beta-Catenin Pathway in Treatment of Colorectal Cancer: Rational and Progress. J Cell Biochem. 2017;118(8):1979-83.
  267. Bahrami A, Amerizadeh F, ShahidSales S, Khazaei M, Ghayour-Mobarhan M, Sadeghnia HR, et al. Therapeutic Potential of Targeting Wnt/β-Catenin Pathway in Treatment of Colorectal Cancer: Rational and Progress. Journal of Cellular Biochemistry. 2017;118(8):1979-83.
  268. Ayatollahi H, Fani A, Karimiani EG, Homaee F, Shajiei A, Sheikh M, et al. Chromogenic in situ hybridization compared with real time quantitative polymerase Chain reaction to evaluate HER2/neu status in breast cancer. Iranian Journal of Pathology. 2017;12(2):128-34.
  269. Asgarian M, Kooshyar MM, Elyasi S, Pakdel AF, Aledavood SA. Adherence to a standardized order form for gastric cancer in a referral chemotherapy teaching hospital, Mashhad, Iran. Middle East Journal of Cancer. 2017;8(4):187-93.
  270. Anvari K, Sima HR, Seilanian Toussi M, Anvari A, Shahidsales S, Memar B, et al. EGFR expression in patients with esophageal squamous cell carcinoma and its association with pathologic response to preoperative chemoradiotherapy: A study in Northeastern Iran. Archives of Iranian Medicine. 2017;20(4):240-5.
  271. Ansari M, Mosalaei A, Ahmadloo N, Rasekhi A, Geramizadeh B, Razmkon A, et al. A comprehensive approach in High-Grade glioma management: Position statement from the Neuro-Oncology scientific club (NOSC), Shiraz, Iran. GMS German Medical Science. 2017;15.
  272. Aledavood SA, Sales SS, Anvari K, Forghani MN, Memar B, Torghabeh AE. Evaluation of tumor resectability rate and pathologic response to preoperative concurrent chemoradiotherapy in locally advanced proximal gastric and esophagogastric junction adenocarcinomas: A clinical trial. International Journal of Cancer Management. 2017;10(5).
  273. Alamdaran SA, Modoodi E, Keshtgar M, Sadeghi R, Forghani MN, Sajjadi S. Assessment of Radio-Guided Occult Lesion Localization Associated with Sonography in Non-Palpable Breast Lesions. Breast Journal. 2017;23(3):367-9.
  274. Afshari ZT, Nikpoor AR, Afshari JT, Ganjali R, Atigh PSG, Shandiz FH, et al. Lack of an association between a functional polymorphism in the MDM2 promoter and breast cancer in women in northeast Iran. Reports of Biochemistry and Molecular Biology. 2017;6(1):112-7.
  275. Toossi MTB, Sabet LSK, Soleymanifard S, Anvari K, Bakhshizadeh M. A comparison of the doses received by normal cranial tissues during different simple model conventional radiotherapeutic approaches to pituitary tumours. Australasian Physical and Engineering Sciences in Medicine. 2016;39(2):517-24.
  276. Tashakori Beheshti A, Mostafavi Toroghi H, Hosseini G, Zarifian A, Homaei Shandiz F, Fazlinezhad A. Carvedilol Administration Can Prevent Doxorubicin-Induced Cardiotoxicity: A Double-Blind Randomized Trial. Cardiology (Switzerland). 2016;134(1):47-53.
  277. Shandiz FH, Janghorban R, Azarkish F, Sedigh S. Effect of treatment delay on survival in patients with breast cancer. Online Journal of Health and Allied Sciences. 2016;15(1):1-4.
  278. ShahidSales S, Hassanian SM, Zadeh RM, Ghayour-Mobarhan M, Gholamin S, Ferns GA, et al. Role of SFRP1 in NPC metastasis-letter. Cancer Prevention Research. 2016;9(5):415.
  279. ShahidSales S, Hassanian SM, Mahdavian Zadeh R, Ghayour-Mobarhan M, Gholamin S, Ferns GA, et al. Role of SFRP1 in NPC Metastasis-Letter. Cancer Prev Res (Phila). 2016;9(5):415.
  280. Salek R, Shahidsales S, Mozafari V. Changing pattern in the clinical presentation of breast cancer in the absence of a screening program over a period of thirty-three years in Iran. Breast. 2016;28:95-9.
  281. Salek R, Hosseini BA, Behravan J, Aledavood A, Sadeghi Ivari M. A survey on the prevalence of IVS14+ 1G> a mutation of the dihydropyrimidine dehydrogenase gene among a group of colorectal cancer patients in northeast iran, the relevance of fluoropyrimidine based chemotherapy toxicity. Reports of Radiotherapy and Oncology. 2016;3(1).
  282. Salek R, Bayatmokhtari N, Homaei Shandiz F, ShahidSales S. The Results of Chemotherapy with Two Variants of Intravenous CMF in Patients with Early Stage Breast Carcinoma; Does Dose Density Matter? Breast Journal. 2016;22(6):623-9.
  283. Saghravanian N, Zamanzadeh M, Meshkat Z, Aghaee MA, Salek R. Evaluation of the prevalence rate and the prognostic effect of human papilloma virus infection in a group of patients with oral cavity squamous cell carcinoma. International Journal of Cancer Management. 2016;9(3):1-8.
  284. Rastgoosalami M, Memar B, Aledavood SA, Fanipakdel A. Evaluation of MAGE-1 cancer-testis antigen expression in invasive breast cancer and its correlation with prognostic factors. International Journal of Cancer Management. 2016;9(4).
  285. Mostaan LV. Changing laws is not equal to changing minds: 22 years of women in surgical fields in Iran. Academic Medicine. 2016;91(8):1036.
  286. Mirzaei H, Khataminfar S, Mohammadparast S, ShahidSales S, Maftouh M, Mohammadi M, et al. Circulating microRNAs as potential diagnostic biomarkers and therapeutic targets in gastric cancer: Current status and future perspectives. Current Medicinal Chemistry. 2016;23(36):4135-50.
  287. Mirzaei H, Gholamin S, Shahidsales S, Sahebkar A, Jafaari MR, Mirzaei HR, et al. MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma. European Journal of Cancer. 2016;53:25-32.
  288. Leon LG, Funel N, Peters GJ, Avan A, Vistoli F, Boggi U, et al. The MEK1/2 inhibitor pimasertib enhances gemcitabine efficacy-letter. Clinical Cancer Research. 2016;22(10):2594.
  289. Kimiafar K, Sarbaz M, Shahid Sales S, Esmaeili M, Javame Ghazvini Z. Breast cancer patients' information needs and information-seeking behavior in a developing country. Breast. 2016;28:156-60.
  290. Khajedaluee M, Babaei A, Vakili R, Valizade N, Shandiz FH, Alavian SM, et al. Sero-prevalence of bloodborne tumor viruses (HCV, HBV, HTLV-I and KSHV infections) and related risk factors among prisoners in Razavi Khorasan province, Iran, in 2008. Hepatitis Monthly. 2016;16(12).
  291. Kermani AT, Vakili R, Dadkhah S, Jafarian AH, Bagheri R. HER-2/neu overxpression in esophageal squamous cell carcinoma (ESCC) and its correlation with patient’s clinicopathological features. International Journal of Cancer Management. 2016;9(5).
  292. Jafarian AH, Taghizadeh Kermani A, Esmaeili J, Roshan NM, Seilanian-Toosi M, Omidi AA, et al. The role of COX-2 and Ki-67 over-expression in the prediction of pathologic response of rectal cancer to neoadjuvant chemoradiation therapy. Indian Journal of Cancer. 2016;53(4):548-51.
  293. Homaei-Shandiz F, Mehrad-Majd H, Tasbandi M, Aledavood A, Afshari JT, Ghavami V, et al. Anti-heat shock protein-27 antibody levels in women with breast cancer: Association with disease complications and two-year disease-free survival. Asian Pacific Journal of Cancer Prevention. 2016;17(10):4655-9.
  294. Elyasi S, Hosseini S, Niazi Moghadam MR, Aledavood SA, Karimi G. Effect of Oral Silymarin Administration on Prevention of Radiotherapy Induced Mucositis: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial. Phytotherapy Research. 2016;30(11):1879-85.
  295. Ebrahimi S, Hosseini M, Ghasemi F, Shahidsales S, Maftouh M, Akbarzade H, et al. Circulating microRNAs as potential diagnostic, prognostic and therapeutic targets in pancreatic cancer. Current Pharmaceutical Design. 2016;22.
  296. Danesh-Sani SA, Sarafraz A, Chamani M, Derakhshandeh H. Paranasal sinuses malignancies: A 12-year review of clinical characteristics. Medicina Oral, Patologia Oral y Cirugia Bucal. 2016;21(5):e626-e30.
  297. Babazadeh M, Pourali L, Attaran N, Nikfarjam Z, Masoudi T, Salehi M. Demographic survey of 600 patients with gynecologic cancers in Mashhad, Iran in 1985-2012. Iranian Journal of Obstetrics, Gynecology and Infertility. 2016;19(2):1-8.
  298. Anvari K, Seilanian Toussi M, Shahidsales S, Motlagh F, Reza Ehsaee M, Afshari F. Treatment Outcomes and Prognostic Factors in Adult Astrocytoma: In North East of Iran. Iran J Cancer Prev. 2016;9(4):e4099.
  299. Anvari K, Gharib M, Saburi A, Javadinia SA. Intracranial mesenchymal chondrosarcoma: Case report and review of literature. Galen Medical Journal. 2016;5(4):219-24.
  300. Alavifard R, Kadkhodayan S, Shandiz FH, Dabbagh VR, Sadeghi R. Is sentinel node mapping possible in surgically removed ectopic axillary breast cancer? A case report. Nuclear Medicine Review. 2016;19:B29-B30.
  301. Shandiz MH, Layen GS, Anvari K, Khalilzadeh M. New methods for optical distance indicator and gantry angle quality control tests in medical linear accelerators: Image processing by using a 3D phantom. Radiation Oncology Journal. 2015;33(1):42-9.
  302. Shandiz FH, Najafi MN, Shaye ZA, Salehi M, Salehi M. Tendency to breast reconstruction after breast mastectomy among Iranian women with breast cancer. Medical Journal of the Islamic Republic of Iran. 2015;29(1).
  303. Shahidsales S, Mobarhan MG, Ghasemi F, Gholamin S, Avan A. Low expression of chloride channel accessory 1 predicts a poor prognosis in colorectal cancer: The question is still open. Cancer. 2015;121(21):3922-3.
  304. Saeidi H, Nasiri MR, Shahidsales S, Kermani AT, Hematti S, Roodbari SS, et al. Evaluation of estrogen receptor expression and its relationship with clinicopathologic findings in gastric cancer. Adv Biomed Res. 2015;4:177.
  305. Saeedi-Saedi H, Shahidsales S, Koochak-Pour M, Sabahi E, Moridi I. Evaluation of emotional distress in breast cancer patients. Iranian Journal of Cancer Prevention. 2015;8(1):36-41.
  306. Saedi HS, Fanipakdel A, Shafaghi A, Ghorbani S. Evaluating the relation between patients-related factors and dissected lymph node ratio in gastric cancer. Indian Journal of Cancer. 2015;52(1):48-51.
  307. Rajabi Mashhadi M, Bagheri R, Abdollahi A, Ghamari MJ, Shahidsales S, Salehi M, et al. The Effect of Neoadjuvant Therapy on Early Complications of Esophageal Cancer Surgery. Iran J Otorhinolaryngol. 2015;27(81):279-84.
  308. Mozaffary PM, Delavarian Z, Amirchaghmaghi M, Dalirsani Z, Mostaan LV, Khadem SS, et al. Secondary involvement of the mandible due to basal cell carcinoma: A case report. Iranian Journal of Medical Sciences. 2015;40(3):277-81.
  309. Moradian S, Walshe C, Shahidsales S, Ghavam Nasiri MR, Pilling M, Molassiotis A. Nevasic audio program for the prevention of chemotherapy induced nausea and vomiting: A feasibility study using a randomized controlled trial design. European Journal of Oncology Nursing. 2015;19(3):282-91.
  310. Memar B, Aledavood A, Shahidsales S, Ahadi M, Farzadnia M, Raziee HR, et al. The prognostic role of tumor marker CA-125 in B-cell non-Hodgkin’s lymphoma. Iranian Journal of Cancer Prevention. 2015;8(1):42-6.
  311. Jafarian AH, Mostaan LV, Roshan NM, Khazaeni K, Parsazad S, Gilan H. Relationship between the expression of matrix metalloproteinase and clinicopathologic features in oral squamous cell carcinoma. Iranian Journal of Otorhinolaryngology. 2015;27(80):219-23.
  312. Hosseini S, Gharib M, Hosseini S. Pre-sacra epidermoid cyst along with cervical cancer: A case report. Iranian Journal of Obstetrics, Gynecology and Infertility. 2015;18(170):17-22.
  313. Bolouri AJ, Pakfetrat A, Tonkaboni A, Aledavood SA, Najafi MF, Delavarian Z, et al. Preventing and therapeutic effect of propolis in radiotherapy induced mucositis of head and neck cancers: A triple-blind, randomized, placebo-controlled trial. International Journal of Cancer Management. 2015;8(5).
  314. Azarkish F, Najmabadi KM, Roudsari RL, Shandiz FH. Factors related to return to work in women after breast cancer in Iran. Iranian Red Crescent Medical Journal. 2015;17(9).
  315. Avan A, Avan A, Maftouh M, Mobarhan MG, Shahidsales S, Gholamin S. Biomarker analysis in CLEOPATRA: Searching for a sensitive prognostic factor in breast cancer. Journal of Clinical Oncology. 2015;33(15):1711-2.
  316. Avan A, Avan A, Maftouh M, Ghayour Mobarhan M, Shahidsales S, Gholamin S. Biomarker Analysis in CLEOPATRA: Searching for a Sensitive Prognostic Factor in Breast Cancer. J Clin Oncol. 2015;33(15):1711-2.
  317. Anvari K, Seilanian-Toussi M, Hosseinzad-Ashkiki H, Shahidsales S. A comparison of 5-HT3 receptor antagonist and metoclopramide in the patients receiving chemotherapeutic regimens including CMF, CAF and CHOP. Iranian Journal of Cancer Prevention. 2015;8(2):84-8.
  318. Anvari K, Samini F, Faraji M, Khooei A, Ghiasi T, Dehghan P. Pituitary glioblastoma: A case report. International Journal of Cancer Management. 2015;8(4).
  319. Anvari K, Kalantari MR, Samini F, Shahidsales S, Seilanian-Toussi M, Ghorbanpour Z. Assessment of clinicopathologic features in patients with pituitary adenomas in Northeast of Iran: A 13-year retrospective study. Iran J Neurol. 2015;14(4):185-9.
  320. Anvari K, Aledavood SA, Toussi MS, Nosrati F, Forghani MN, Mohtashami S, et al. A phase II trial of neoadjuvant concurrent chemo-radioptherapy followed by resection for esophageal carcinoma. Journal of Research in Medical Sciences. 2015;20(8).
  321. Anvari K, Aledavood SA, Toussi MS, Forghani MN, Mohtashami S, Rajabi MT, et al. A clinical trial of neoadjuvant concurrent chemoradiotherapy followed by resection for esophageal carcinoma. Journal of Research in Medical Sciences. 2015;20(8):751-6.
  322. Aledavood SA, Torghabeh AE, Shandiz FH, Memar B. Cardiac involvement in non-hodgkin lymphoma, an incidental large atrial mass: A case report. International Journal of Cancer Management. 2015;8(5).
  323. Taghizadeh-Kermani A, Yahouiyan SZ, AliAkbarian M, Toussi MS. Prognostic significance of metastatic lymph node ratio in patients with gastric cancer: An evaluation in north-east of Iran. Iranian Journal of Cancer Prevention. 2014;7(2):73-9.
  324. Taghizadeh-Kermani A, Jafarian AH, Ashabyamin R, Seilanian-Toosi M, Pourali L, Asadi M, et al. The stromal overexpression of CD10 in invasive breast cancer and its association with clincophathologic factors. Iranian Journal of Cancer Prevention. 2014;7(1):17-21.
  325. Soleymanifard S, Toossi MT, Khosroabadi M, Noghreiyan AV, Shahidsales S, Tabrizi FV. Assessment of skin dose modification caused by application of immobilizing cast in head and neck radiotherapy. Australas Phys Eng Sci Med. 2014;37(3):535-40.
  326. Sharifi N, Shahidsales S, Haghighi F, Hosseini S. Gestational throphoblastic diseases in North East of Iran: 10 years (2001-2010) prospective epidemiological and clinicopathological study. Adv Biomed Res. 2014;3:55.
  327. Shandiz FH, Torghabeh AE, Yousefi Z, Sharifi N, Jafarian AH, Dehghan P, et al. Primary non-hodgkin ovarian lymphoma: A case report. Iranian Journal of Obstetrics, Gynecology and Infertility. 2014;17(112):15-9.
  328. Shahidi J, Taghizadeh-Kermani A, Gohari MR, Ghavamnasiri MR, Khoshroo F, Pourali L, et al. Changes in daily activities of cancer patients after diagnosis: How do Canadian and Iranian patients perceive the change? Iranian Journal of Cancer Prevention. 2014;7(1):28-34.
  329. Salehi M, Shandiz FH, Najafi MN, Salehi M. Development and validation of a questionnaire to assess the attitudes of mastectomy patients about breast reconstruction. Iranian Journal of Obstetrics, Gynecology and Infertility. 2014;16(90):16-24.
  330. Saedi HS, Mansour-Ghanaei F, Joukar F, Shafaghi A, Shahidsales S, Atrkar-Roushan Z. Neoadjuvant chemoradiotherapy in non-cardia gastric cancer patients - does it improve survival? Asian Pacific Journal of Cancer Prevention. 2014;15(20):8667-71.
  331. Sadr-Nabavi A, Dastpak M, Homaei-Shandiz F, Bahrami AR, Bidkhori HR, Raeesolmohaddeseen M. Analysis of novel mutations in BRCA1 in Iranian families with breast cancer. Hereditas. 2014;151(2-3):38-42.
  332. Mousavi SN, Samini F, Nematy M, Philippou E, Safarian M, Tavallaiee S, et al. Hyperglycemia and antibody titres against heat shock protein 27 in traumatic brain injury patients on parenteral nutrition. Iranian Journal of Basic Medical Sciences. 2014;17(2):119-22.
  333. Moradian S, Shahidsales S, Ghavam Nasiri MR, Pilling M, Molassiotis A, Walshe C. Translation and psychometric assessment of the Persian version of the Rhodes Index of Nausea, Vomiting and Retching (INVR) scale for the assessment of chemotherapy-induced nausea and vomiting. Eur J Cancer Care (Engl). 2014;23(6):811-8.
  334. Hasanzadeh M, Zamiri-Akhlaghi A, Hassanpoor-Moghaddam M, Shahidsales S. Vulvar carcinoma in pregnant women aged less than 40 years: case report. Iran J Cancer Prev. 2014;7(3):175-8.
  335. Hasanzadeh M, Naderi HR, Hoshyar AH, Shabane S, Shahidsales S. Female genital tract tuberculosis presenting as ovarian cancer. Journal of Research in Medical Sciences. 2014;19(2):184-9.
  336. Gholamin S, Fiuji H, Maftouh M, Mirhafez R, Shandiz FH, Avan A. Targeting c-MET/HGF signaling pathway in upper gastrointestinal cancers: Rationale and progress. Current Drug Targets. 2014;15(14):1302-11.
  337. Ayatollahi H, Javan AO, Khajedaluee M, Shahroodian M, Hosseinzadeh H. Effect of Crocus sativus L. (Saffron) on coagulation and anticoagulation systems in healthy volunteers. Phytotherapy Research. 2014;28(4):539-43.
  338. Anvari K, Seilanian Toussi M, Bahadorkhan G, Bitaghsir M, Heidari M, Fazl Ersi M, et al. Treatment Outcomes and Prognostic Factors in Pediatric Non-brainstem Astrocytoma in North East of Iran. Iran J Cancer Prev. 2014;7(2):96-100.
  339. Aledavood SA, Ghavam-Nasiri MR, Ghaffarzadegan K, Raziee HR, Saboori G, Anvari K, et al. Hepatitis-C infection incidence among the non-Hodgkin's B-cell lymphoma patients in the Northeast of Iran. Iranian Journal of Cancer Prevention. 2014;7(3):147-51.
  340. Taghizadeh Kermani A, Bagheri R, Tehranian S, Shojaee P, Sadeghi R, N. Krag D. Accuracy of sentinel node biopsy in the staging of non-small cell lung carcinomas: Systematic review and meta-analysis of the literature. Lung Cancer. 2013;80(1):5-14.
  341. Salehi M, Moradi-Lakeh M, Salehi MH, Nojomi M, Kolahdooz F. Meat, fish, and esophageal cancer risk: A systematic review and dose-response meta-analysis. Nutrition Reviews. 2013;71(5):257-67.
  342. Pourali L, Kermani Taghizadeh A, Ghavamnasiri MR, Khoshroo F, Hosseini S, Asadi M, et al. Incidence of chemotherapy-induced amenorrhea after adjuvant chemotherapy with taxane and anthracyclines in young patients with breast cancer. Iranian Journal of Cancer Prevention. 2013;6(3):147-50.
  343. Mostaan LV, Tabari A, Amiri P, Ashtiani MK, Mahdkhah A, Yazdani N, et al. Survivin gene polymorphism association with tongue squamous cell carcinoma. Genetic Testing and Molecular Biomarkers. 2013;17(1):74-7.
  344. Mostaan LV, Irani S, Rajati M, Memar B. Mandibular metastasis from follicular thyroid carcinoma: A rare case after twelve years. Archives of Iranian Medicine. 2013;16(9):557-9.
  345. Mafi AR, Babazadeh S, Shandiz FH, Razzaghi Z, Tabatabaeefar M, Sobhi S, et al. Risk factors of developing a second malignancy following treatment of a first primary breast cancer. Iranian Journal of Cancer Prevention. 2013;6(SUPPL.1).
  346. Anvari K, Fanipakdel A, Davoudi Y. The effect of surveillance on the outcome of breast cancer patients. Iranian Journal of Cancer Prevention. 2013;6(1):17-24.
  347. Zahedi H, Mehrshad N, Anvari K. Intelligent modelling of oesophageal cancer treatment and its use to determine the dose of chemotherapy drug. Journal of Medical Engineering and Technology. 2012;36(5):261-6.
  348. Yazdani N, Sayahpour FA, Haghpanah V, Amiri P, Shahrabi-Farahani M, Moradi M, et al. Survivin gene polymorphism association with papillary thyroid carcinoma. Pathology Research and Practice. 2012;208(2):100-3.
  349. Vossughinia H, Goshayeshi LA, Rafatpanah Bayegi H, Sima H, Kazemi A, Erfani S, et al. Prevalence of hepatitis C virus genotypes in Mashhad, Northeast Iran. Iranian Journal of Public Health. 2012;41(9):56-61.
  350. Saedi HS, Pour MK, Sabahi E, Shahidsales S. Assessment of the psychological distress difficulties in patients with cancer using the national comprehensive cancer network rapid screening measure. Chinese-German Journal of Clinical Oncology. 2012;11(8):472-7.
  351. Saedi HS, Nasiri MRG, Shahidsales S, Taghizadeh A, Mohammadian N. Comparison of hormone receptor status in primary and recurrent breast cancer. Iranian Journal of Cancer Prevention. 2012;5(2):69-73.
  352. Mostaan LV, Yazdani N, Madani SZ, Borghei H, Mortazavi S, Ojani L, et al. Frozen section as a diagnostic test for major salivary gland tumors. Acta Medica Iranica. 2012;50(7):460-2.
  353. Javan H, Gholami H, Assadi M, Pakdel AF, Sadeghi R, Keshtgar M. The accuracy of sentinel node biopsy in breast cancer patients with the history of previous surgical biopsy of the primary lesion: Systematic review and meta-analysis of the literature. European Journal of Surgical Oncology. 2012;38(2):95-109.
  354. Hemati S, Jolfaie NA, Gookizadeh A, Rafienia M, Ghavamnasiri MR. The effects of vitamin E and selenium on cisplatininduced nephrotoxicity in cancer patients treated with cisplatin-based chemotherapy: A randomized, placebo-controlled study. Journal of Research in Medical Sciences. 2012;17(1 SPL.1):S49-S58.
  355. Bahreyni Toossi MT, Ghorbani M, Makhdoumi Y, Taheri M, Homaee Shandiz F, Zahed Anaraki S, et al. A retrospective analysis of rectal and bladder dose for gynecological brachytherapy treatments with GZP6 HDR afterloading system. Reports of Practical Oncology and Radiotherapy. 2012;17(6):352-7.
  356. Aryana K, Gholizadeh M, Momennezhad M, Naji M, Aliakbarian M, Forghani MN, et al. Efficacy of high-energy collimator for sentinel node lymphoscintigraphy of early breast cancer patients. Radiology and Oncology. 2012;46(1):75-80.
  357. Anvari K, Toussi MS, Kalantari M, Naseri S, Shahri MK, Ahmadnia H, et al. Expression of Bcl-2 and Bax in advanced or metastatic prostate carcinoma. Urology Journal. 2012;9(1):381-8.
  358. Anvari K, Izadpanahi P, Memar B. Anorectal melanoma: A 10-year study in the North-East of Iran. Iranian Journal of Cancer Prevention. 2012;5(4):221-4.
  359. Anvari K, Aledavood S, Tousi MS, Nosrati F. A Phase II Trial of Neoadjuvant Concurrent Chemo-Radioptherapy Containing Cisplatin and 5-Fu Followed by Resection for Esophageal Carcinoma. Annals of Oncology. 2012;23:ix248.
  360. Amir AS, Azar FP, Sahram N, Naser FM, Na'ma MR, Farid F, et al. Prevalence of occult metastases in axillary sentinel lymph nodes of breast carcinoma. Polish Journal of Pathology. 2012;63(1):40-4.
  361. Aledavood SA, Amirabadi A, Memar B. Non surgical treatment of sacral osteosarcoma. Iranian Journal of Cancer Prevention. 2012;5(1):46-9.
  362. Aledavood A, Nasiri MRG, Memar B, Shahidsales S, Raziee HR, Ghafarzadegan K, et al. Primary gastrointestinal lymphoma. Journal of Research in Medical Sciences. 2012;17(5):487-90.
  363. Seraj JM, Yazdani N, Ashtiani ZO, Seraj SM, Hasheminasab SM, Memar B, et al. TP53 gene expression in HPV-positive oral tongue SCC and its correlation with nodal metastasis. Pathology Research and Practice. 2011;207(12):758-61.
  364. Ramin S, Azar FP, Malihe H. Methylene blue as the safest blue dye for sentinel node mapping: Emphasis on anaphylaxis reaction. Acta Oncologica. 2011;50(5):729-31.
  365. Nabizadeh Marvast M, Sima HR, Ghaffarzadehgan K, Taghizadeh Kermani A, Norouzi N. Clinicopathological significance of macrophage migration inhibitory factor and its relation with P53 in gastric cancer. Journal of Gastrointestinal Cancer. 2011;42(1):5-10.
  366. Mostaan LV, Khorsandi MT, Sharifian SMR, Shandiz FH, Mirashrafi F, Sabzari H, et al. Correlation between E-cadherin and CD44 adhesion molecules expression and cervical lymph node metastasis in oral tongue SCC: Predictive significance or not. Pathology Research and Practice. 2011;207(7):448-51.
  367. Momennezhad M, Zakavi SR, Dabbagh Kakhki VR, Jangjoo A, Ghavamnasiri MR, Sadeghi R. Scatterogram: A method for outlining the body during lymphoscintigraphy without using external flood source. Radiology and Oncology. 2011;45(3):184-8.
  368. Khedri A, Nejat-Shokouhi A, Salek R, Esmaeili H, Mokhtarifar A, Heravi RE, et al. Association of the colorectal cancer and MDR1 gene polymorphism in an Iranian population. Molecular Biology Reports. 2011;38(5):2939-43.
  369. Imani Moghaddam M, Davachi B, Mostaan LV, Langaroodi AJ, Memar B, Azimi SA, et al. Evaluation of the sonographic features of metastatic cervical lymph nodes in patients with head and neck malignancy. Journal of Craniofacial Surgery. 2011;22(6):2179-84.
  370. Aliakbarian M, Memar B, Jangjoo A, Zakavi SR, Reza Dabbagh Kakhki V, Aryana K, et al. Factors influencing the time of sentinel node visualization in breast cancer patients using intradermal injection of the radiotracer. American Journal of Surgery. 2011;202(2):199-202.
  371. Akbari A, Razzaghi Z, Homaee F, Khayamzadeh M, Movahedi M, Akbari ME. Parity and breastfeeding are preventive measures against breast cancer in Iranian women. Breast Cancer. 2011;18(1):51-5.
  372. Mofrad MH, Shandiz FH, Roodsare FV, Moghiman T. Evaluation of ovarian cysts in breast cancer cases on tamoxifen. Asian Pacific Journal of Cancer Prevention. 2010;11(1):161-4.
  373. Memar B, Sadeghi R, Ayati NK, Aledavood SA, Tghizadeh A, Naseri S, et al. The value of touch imprint cytology and frozen section for intra-operative evaluation of axillary sentinel lymph nodes. Polish Journal of Pathology. 2010;61(3):161-5.
  374. Jangjoo A, Naser Forghani M, Mehrabibahar M, Sadeghi R. Anaphylaxis reaction of a breast cancer patient to methylene blue during breast surgery with sentinel node mapping. Acta Oncologica. 2010;49(6):877-8.
  375. Tatari F, Salek R, Mosaffa F, Khedri A, Behravan J. Association of C3435T single-nucleotide polymorphism of MDR1 gene with breast cancer in an Iranian population. DNA and Cell Biology. 2009;28(5):259-63.
  376. Saeidi Saedi H, Golmohammadi Zadeh SH, Hamedanchi A, Mohammadian Roshan N, Malek Zadeh M, Esmaeely E. Primary atrial lymphoma in a patient with dyspnea. Iranian Journal of Cancer Prevention. 2009;2(1):59-62.
  377. Homaei-Shandiz F, Brook A, Tavakol Afshari J, Mohammad Pour AH, Ganjali R, Morad Abbassi Fuladi J, et al. Study the frequncy of CYP2D6*4 null allele in Iranian population. Pharmacologyonline. 2009;3:1003-7.
  378. Toosi MS, Anvari K, Aledavood A, Nowferesti G, Mohtashami S. An audit of combined modality therapy for esophageal squamous cell carcinoma from a teaching hospital in Iran. Indian Journal of Gastroenterology. 2008;27(1):33-4.
  379. Sahraian A, Fazelzadeh A, Mehdizadeh AR, Toobaee SH. Burnout in hospital nurses: A comparison of internal, surgery, psychiatry and burns wards. International Nursing Review. 2008;55(1):62-7.
  380. Raziee HR, Kermani AT, Ghaffarzadegan K, Shakeri MT, Ghavamnasiri MR. HER-2/neu expression in resectable gastric cancer and its relationship with histopathologic subtype, grade, and stage. Iranian Journal of Basic Medical Sciences. 2007;10(2):139-45.